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Abstract 
 
This dissertation investigates the use of intraprocedure acoustic radiation force 
impulse (ARFI) imaging for visualization of radiofrequency ablation (RFA) lesions 
during cardiac transcatheter ablation (TCA) procedures.  Tens of thousands of TCA 
procedures are performed annually to treat atrial fibrillation (AF) and other cardiac 
arrhythmias.  Despite the use of sophisticated electroanatomical mapping (EAM) 
techniques to validate the modification of the electrical substrate, post-procedure 
arrhythmia recurrence is common due to incomplete lesion delivery and electrical 
conduction through lesion line discontinuities.  The clinical demand for an imaging 
modality that can visually confirm the presence and completeness of RFA lesion lines 
motivated this research. 
ARFI imaging is an ultrasound-based technique that transmits radiation force 
impulses to locally displace tissue and uses the tissue deformation response to generate 
images of relative tissue stiffness.  RF-induced heating causes irreversible tissue necrosis 
and contractile protein denaturation that increases the stiffness of the ablated region. 
Preliminary in vitro and in vivo feasibility studies determined RF ablated myocardium 
appears stiffer in ARFI images. 
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This thesis describes results for ARFI imaging of RFA lesions for three research 
milestones:  1) an in vivo experimental verification model, 2) a clinically translative 
animal study, and 3) a preliminary clinical feasibility trial in human patients.  In all 
studies, 2-D ARFI images were acquired in normal sinus rhythm and during diastole to 
maximize the stiffness contrast between the ablated and unablated myocardium and to 
minimize the bulk cardiac motion during the acquisition time. 
The first in vivo experiment confirmed there was a significant decrease in the 
measured ARFI-induced displacement at ablation sites during and after focal RFA; the 
displacements in the lesion border zone and the detected lesion area stabilized over the 
first several minutes post-ablation.  The implications of these results for ARFI imaging 
methods and the clinical relevance of the findings are discussed. 
The second and third research chapters of this thesis describe the system 
integration and implementation of a multi-modality intracardiac ARFI imaging-EAM 
system for intraprocedure lesion evaluation.  EAM was used to guide the 2-D ARFI 
imaging plane to targeted ablation sites in the canine right atrium (RA); the presence of 
EAM lesions markers and conduction disturbances in the local activation time (LAT) 
maps were used to find the sensitivity and specificity of predicting the presence of RFA 
lesion with ARFI imaging.  The contrast and contrast-to-noise ratio between RFA lesion 
and unablated myocardium were calculated for ARFI and conventional ICE images.  
The opportunities and potential developments for clinical translation are discussed.  
  
vi 
The last research chapter in this thesis describes a feasibility study of intracardiac 
ARFI imaging of RFA lesions in clinical patients.  ARFI images of clinically relevant 
ablation sites were acquired, and this pilot study determined ARFI-induced 
displacements in human myocardium decreased at targeted ablation sites after RF-
delivery.  The challenges and successes of this pilot study are discussed. 
This work provides evidence that intraprocedure ARFI imaging is a promising 
technology for the visualization of RFA lesions during cardiac TCA procedures.  The 
clinical significance of this research is discussed, as well as challenges and 
considerations for future iterations of this technology aiming for clinical translation.  
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Chapter 1:  Introduction  
 
 
Normal sinus rhythm (NSR) is the intrinsic electrical activation of the healthy 
human heart that coordinates the mechanical contraction of the four cardiac chambers.  
In NSR, each heart beat is initiated by the depolarization of the sinoatrial (SA) node, a 
specialized group of pacemaker cells located in the roof of the right atrium (RA).  The 
SA node depolarization starts a conduction wavefront that spreads uniformly through 
the RA and along specialized conduction tracts to the atrioventricular (AV) node; the 
wavefront spreads synchronously into the left atrium (LA) through a specialized 
conduction tract known as Bachmann’s bundle.  The AV node delays the excitation 
wavefront while the atria contract, then proceeds to depolarize the right ventricle (RV) 
and left ventricle (LV) along the bundle of His and the Purkinje fiber network.   
Cardiac arrhythmias are characterized by disturbances in the NSR of the heart; 
heart rhythm disturbances can cause abnormal heart rates and asynchronous cardiac 
contraction.  Atrial fibrillation (AF) is a cardiac arrhythmia characterized by rapid and 
dyssynchronous beating of the atria.  It is typically caused by multiple re-entering 
electrical wavefronts wandering chaotically through the atrial tissue.  The disorganized 
atrial conduction pattern causes rapid and irregular ventricular beats, which 
significantly increase cardiac related morbidity and mortality over time. 
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AF is the most commonly diagnosed arrhythmia in clinical practice.  Over 3 
million people in the United States are diagnosed with AF annually, and diagnoses are 
expected to more than double over the next 40 years.1-3 
Radiofrequency (RF) transcatheter cardiac ablation (TCA) is a curative treatment 
for AF.4, 5  TCA aims to restore the normal rhythm of the heart by directly destroying or 
electrically isolating abnormally conducting myocardium with lines of radiofrequency 
ablation (RFA) lesions.  To eliminate the arrhythmia RFA lesions must fully ablate the 
target ablation site and extend the full depth of the myocardium (transmurality), and 
RFA lesion lines must not contain conductive gaps between lesions that can propagate 
electrical wavefronts.6-8 
The biophysics and pathophysiology of RFA lesion formation has been 
comprehensively studied, but the efficacy of predicting lesion size using delivery 
parameters such as RF duration, current, and impedance is unreliable because 
convective cooling at the ablation site and inconsistent electrode-endocardium contact in 
the beating heart significantly affects lesion formation.9-16  Without a reliable method to 
assess lesion presence, size, and transmurality, post-TCA arrhythmia recurrence is 
common and a significant number of patients (10-30%) require additional ablation 
procedures.4, 17-21  Furthermore, electrical reconnection across discontinuous lesion lines 
has been found in many patients with arrhythmia recurrence.21  Ideally, direct 
visualization of the ablated region immediately following RF-delivery would provide 
 3 
feedback of RFA lesion presence and transmurality as well as lesion line continuity 
during the initial clinical procedure. 
Acoustic radiation force impulse (ARFI) imaging is an ultrasound-based 
elasticity imaging technique that creates two-dimensional (2-D) images of relative tissue 
stiffness.22  ARFI imaging uses ultrasonic radiation force impulses to mechanically 
displace tissue and conventional ultrasound methods to monitor the tissue response.  
The axial tissue displacement magnitude (~10 μm) is calculated using correlation based 
time-delay or phase-shift estimator methods.23, 24  The magnitude of the measured tissue 
displacement is inversely proportional to the tissue stiffness, and a 2-D image of the 
ARFI-induced tissue displacement characterizes relative tissue stiffness.23, 25, 26 
RF-induced tissue heating causes irreversible denaturation and coagulation of 
intracellular and contractile proteins; changes in tissue viscoelasticity have been 
correlated with the thermal denaturation of myocardial proteins.27-30  Preliminary work 
has shown ARFI imaging provides accurate visualization of RFA lesions in vitro based 
on the stiffness changes caused by RF ablation.31, 32 
The central hypothesis of this research was: ARFI imaging can be used for 
intraprocedure visualization of acute RFA lesions during transcatheter ablation 
procedures.  Evidence to support this hypothesis was investigated in four experimental 
aims.  In the first aim, an experiment was performed to show that in vivo ARFI imaging 
could visualize relative tissue stiffness changes during and immediately after RFA, and 
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to show that ARFI determined lesion stiffness and detected lesion area were temporally 
and spatially stable over an acute monitoring period.  The second aim addressed the 
problem of finding lesions in the beating heart using 2-D intracardiac ARFI imaging, 
which has a limited frame rate (< 1 Hz when diastolic-gated) and narrow field of view 
(FOV).  An experiment was conducted to test the accuracy of identifying RFA lesion 
sites with an integrated ARFI imaging-electroanatomical mapping system.  The third 
aim was used to verify the presence of conduction disturbances at RFA lesion sites 
identified with ARFI imaging during TCA.  This experiment sought to confirm that 
ARFI imaging determined lesion assessment was consistent with EAM local activation 
time (LAT) mapping, which is the clinical gold-standard used to determine the presence 
of lesions.  In the fourth aim, ARFI images were used to show local myocardial stiffness 
changes at targeted RF ablation sites in human patients.  These studies were the ‘first in 
human’ experiments to demonstrate these changes.  The discoveries and challenges 
encountered when translating this technology to pre-clinical and clinical models are 
addressed from a physiological, imaging implementation, and procedural method 
standpoint. 
This thesis is organized as follows: chapter 2 provides background information 
about the mechanism and treatment of AF, including information about TCA and the 
biophysics and pathophysiology of RFA.  The fundamental concepts behind ARFI 
imaging are also described in this chapter.  Chapter 3 presents an experimental method 
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for ARFI imaging of RFA-induced myocardial stiffness changes during lesion formation 
and the acute stability of the measured ARFI-induced displacements in living 
myocardium.  Chapter 4 describes the integration and testing of an intracardiac ARFI 
imaging-EAM system, as well as the accuracy of evaluating RFA lesions with this multi-
modality system during TCA in an animal model.  In chapter 5, the integrated ARFI 
imaging-EAM system was used to evaluate the accuracy of identifying electrical 
conduction disturbances in canine atria with intraprocedure ARFI imaging of RFA 
lesions.  Chapter 6 presents and describes preliminary intracardiac ARFI images of 
clinically targeted RFA ablation sites in a pilot group of clinical ablation patients.  
Chapter 7 presents the final conclusions and clinical implications of this thesis and 
discusses future directions for this research. 
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Chapter 2:  Background 
 
 
2.1 Management and Treatment of Atrial Fibrillation 
2.1.1 Mechanism and Prevalence of Atrial Fibrillation 
Atrial fibrillation (AF) is characterized by rapid (>350 beats per minute) and 
irregular atrial conduction.  An important component of AF initiation and persistence is 
functional re-entry involving multiple wavelets.4, 33  Conduction re-entry occurs when a 
propagating wavelet re-excites an area that had previously been activated by another 
present wavelet, creating a sustained conduction rotor.33  Two types of re-entry initiation 
mechanisms can cause AF: 1) focal electrical triggers, typically from the muscle tissue 
surrounding and adjacent to the pulmonary veins (PV) or 2) an atrial substrate 
susceptible to the development of conduction re-entry rotors.4, 34-37 
For case 1, an electrical depolarization not initiated by the sinus node (ectopic 
beat) activates the atrium before the normal sinus beat.  A re-entry rotor can occur when 
this “early” wavefront encounters partially or completely refractory myocardium.4, 34  
Cells capable of “abnormal automaticity” have been discovered in the myocardial tissue 
around the PV in the left atrium (LA), and spontaneous firing of these abnormal cells 
produce focal triggers that can initiate AF.4, 38-41  Other potential AF foci can be found at 
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multiple sites in the atria, including the tissue at the Ligament of Marshall (LoM) and 
along the posterior left atrium (LA).4, 42 
In case 2, the reentrant circuit is caused by the presence of two distinct 
conduction pathways in the myocardium: a path of normal propagation and a second 
path of “slow” conduction often caused by structural (scar or fibrosis) or functional 
block in the atrial substrate.36  Conduction re-entry occurs when impulses traversing the 
area of slow conduction take long enough to propagate that the myocardium of the 
normal pathway has recovered; the slow activation wavefront can then re-enter 
previously the excited myocardium creating a conduction rotor.4, 34-36, 43, 44  
AF is primarily proliferated and sustained by the following mechanisms: 1) rapid 
activation of the atrium due to functional re-entry that produces heterogeneous 
conduction delays and independent re-entry wavelets in other regions of the atrial and 
2) chronic rapid atrial activation that causes alterations of the atrial refractory periods 
due to changes in the cellular excitability via calcium overload and transcriptional 
regulation. 4, 34, 35, 45, 46 
AF affects approximately 1% of the general population and increases to 8-10% in 
individuals over 80 years old.1  Diagnoses of AF are increasing annually, and more than 
3 million people in the United States are expected to be diagnosed in the next year 
alone.1-3  Patients with AF often see decreased quality of life and may experience 
symptoms such as severe shortness of breath, chest pain, fainting, weakness, and/or 
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heart palpitations.47  Patients with a history of AF also have an increased risk of heart 
failure and stroke.42, 48, 49 
2.1.2 Treatment of Atrial Fibrillation 
The first line therapy for AF is rhythm management with pharmaceuticals.4  
Unfortunately, a high number of patients (approximately 43%) see no positive response 
to initial drug therapy.4, 50, 51  Anti-arrhythmic drugs may also become less effective over 
time and can cause harmful side effects.50 
An alternative to drug related treatment of AF is catheter-based surgical 
intervention, or transcatheter cardiac ablation (TCA).  TCA uses an intracardiac catheter-
electrode to create focal or continuous lines of transmural lesions to 1) directly ablate 
abnormally automatic tissue, 2) electrically isolate tissue with abnormal automaticity, or 
3) modify potential re-entry circuits by ablating areas of slow conduction.  The 
successful isolation or elimination of these areas restores NSR in many patients.  
Approximately one-third of AF patients are candidates for TCA and tens of thousands 
of procedures are performed each year.4, 18, 52 
As mentioned previously, the PV muscle sleeve and surrounding myocardium 
are frequent locations of arrhythmia genesis; therefore, the most common TCA 
technique for treating AF is LA pulmonary vein isolation (PVI).  Circumferential PVI 
techniques aim to completely encircle and electrically isolate the PV with continuous 
lesion lines to prevent ectopic beats from conducting into the atria.4, 38, 53, 54  Segmental 
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PVI is another approach where discrete electrical connections between the PV muscle 
and atrium are directly targeted to electrically isolate the PV without a complete 
circumferential ablation.55  For patients with advanced AF or AF triggering mechanisms 
not associated with the PV, additional focal ablation is done at other sites thought to 
participate in the genesis of the AF.  Arrhythmogenic substrate is found using local atrial 
electrograms (EG), and transseptal puncture (TSP) techniques are used to introduce the 
ablation and EG sensing catheters into the LA.4, 41, 56   
The published success rates for TCA are typically between 60-90% for both 
paroxysmal (intermittent) and persistent AF; treatment is often less successful for 
patients with persistent AF or that show evidence of a diffuse atrial myopathy 
(measurable deterioration of the muscle tissue and function) than for patients with 
paroxysmal AF or no evidence of atrial myopathy.4, 17, 57  Incomplete ablation (gaps in 
isolation lines, non-transmural lesions) with electrical reconnection or failure to target 
critical triggers or drivers of AF is the primary cause of the limited treatment success 
rate.4, 21  Recurrence of the arrhythmia after unsuccessful procedures requires additional 
TCA procedures.4, 17-21 
Overall, TCA procedures are effective, minimally invasive, and have low 
morbidity and mortality rates, but often require multiple procedures to stop the 
arrhythmia.4, 52 
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2.2 Radiofrequency Ablation 
2.2.1 Biophysics of Radiofrequency Ablation 
RF-induced tissue heating causes tissue thermocoagulation necrosis and is 
produced by applying an alternating current between the catheter tip electrode and a 
dispersive ground electrode adhered to the patient’s skin.43, 58-60  As the RF current passes 
through the resistive myocardium, heat is generated in the region surrounding the 
electrode where the current density is the highest.  This local heating creates a 
permanent lesion of myocyte necrosis. 
Assuming the electrode tip can be modeled as a spherical point source, the 
current density at the electrode tip can be described using a quasi-static approach: the 
current density (J, units A/m2) a distance of radius r from the source is equal to the total 
current source strength Io (units A) divided by the spherical surface area (4πr2, units m2).  
This relationship is presented in equation 1.  The resistive heating of tissue from applied 
currents can be described with Joule’s first law of heating, which states the heat 
production per unit volume (h, units W/m3) is proportional to the current density 
squared times the tissue resistivity (ρR, units m/S; reciprocal of tissue conductance, σt = 
0.50 S/m at 37C˚).  This relationship is shown in equation 2. 
 
  
  
    
                                                                      
  
    
 
      
                                                                
 11 
 
This relationship shows the direct resistive heating decreases significantly over a 
short distance (proportional to 1/r4).   Therefore, only the ~2 mm of tissue nearest the 
electrode tip experiences direct heating, and larger lesion formation is the result of 
passive thermal conduction.  RF-induced hyperthermia in the passively heated region of 
the lesion is governed by the bioheat transfer equation (equation 3).43, 58, 61, 62  
 
   
  
 
 
    
[                 ]              
 
The first heat source term quantifies the heat transfer from passive thermal conduction, 
where the rate of change in local tissue temperature (units ˚C/s) is equal to the heat 
transfer densities (units W/m3) of the heat flow sources (RF) divided by the tissue 
density (units kg/m3) and specific heat (units kJ/kg·˚C). Terms Qm, Qi, and Qh represent 
the volumetric heat transfer generated by cellular metabolic processes, the RF current 
power dissipation, and the heat loss from blood profusion, respectively.  Metabolic heat 
generation is considered negligible (Qm = 0) compared to the electrical heating.  Direct 
heating of the tissue due to current power dissipation is also considered negligible (Qi = 
0) because the tissue heating more than ~2 mm from the source is primarily due to 
passive heat conduction.43, 63, 64  Heat losses from blood profusion (Qh) can be quantified 
using equation 4 where cb is the specific heat of the blood (units kJ/kg·C˚), Wb is blood 
profusion per unit volume (units kg/m3·s), and Tb is the blood temperature in the human 
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body (C˚).59  The thermo-material constants for cardiac tissue and blood are assumed to 
be uniform and are presented in tables 1 and 2.59, 61, 62, 65, 66   
 
 
                                                              
 
 
Table 1: Thermal-material properties of cardiac tissue. 
  
 
 
 
 
Table 2: Thermal-profusion properties of blood. 
 
 
 
 
While mathematical models can provide a basic understanding of the biophysics 
of RFA lesions formation, many variable factors such as catheter-tissue contact and 
convective flow at the endocardial surface also significantly affect lesion formation.10, 12, 
13, 67, 68 
2.2.2 Physiology of Radiofrequency Ablation Lesions 
When myocardium is heated to temperatures greater than 48˚C tissue desiccation 
and cellular protein denaturation and thermocoagulation occurs, resulting in the 
Material Property Symbol Value Units 
Density ρt 1.06x10-3 kg/m3 
Specific heat ct 3.7 kJ/kg·˚C 
Thermal Conductivity kt 0.59 W/m·˚C 
Conductance σt 0.50 S/m at 37C˚ 
Property Symbol Value Units 
Blood profusion Wb 5 kg/m3·s 
Specific heat cb 3.6 kJ/kg·˚C 
Temperature Tb 37 ˚C 
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eradication of local electrical conduction and mechanical contraction.69, 70  The duration 
of the hyperthermia also affects the extent of myocyte necrosis.  The amount of thermal 
damage incurred by myocytes as a function of temperature and time can be quantified 
by the time integral of the Arrhenius relationship (equation 5).  In this relationship, Ω is 
a unitless quantifier of cellular thermal damage and is a function of temperature (T, ˚K), 
time (t, seconds), and the ideal gas constant (R = 8.315 J/mol·K),  as well as material 
properties for cardiac tissue including the activation energy for irreversible damage (ΔE 
= 5.87x105 J/mol) and a kinetics frequency factor that accounts for morphological changes 
in the extracellular connective tissue causes by the thermal coagulation of the proteins 
(A = 2.39x1092 s-1).58, 61, 71 
 
   ∫                                                         
 
 
 
 
Irreversible injury to both myocyte organelles and contractile proteins occurs when Ω is 
greater than 1.58, 71  At this critical value the survival probability of a single myocyte is 
63%, or for a cellular volume where 63% of cells have become necrotic.64, 71   
Changes in viscoelasticity have been correlated with the degree of protein 
coagulation during tissue heating, and the ablated region becomes stiffer as the 
extracellular (collagen and elastin fibrils) and contractile (actin and myosin in 
myofilaments) proteins irreversibly denature.27, 28, 30, 72, 73  Irreversible loss of 
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electrophysiological function is seen in the directly heated lesion core and the passively 
heated zone of complete thermocoagulation (figure 1).  
The myocardium surrounding the pathological lesion can be temporarily 
affected by the diffusive hyperthermia immediately following ablation.69, 74, 75  In this 
region the effects of tissue heating are reversible and insufficient for complete electrical 
block (Ω ≤ 0.5).  This “border” zone is characterized by reversibly injured or “stunned” 
myocytes that suffer a temporary loss of cellular excitability and immune-fluid 
infiltration (edema).69, 74-76  Regions of viable myocytes without cellular excitability (less 
negative resting membrane potential, decrease in the maximum rate of potential change 
and action potential duration) have been reported to occur within 2 mm of the lesion 
edge.75  These effects are transient (~30 to 60-min) and compromise the accuracy of 
electrophysiology (EP) recordings immediately post ablation.74, 77, 78  Unrelated to the loss 
of conductivity, the injured myocytes in the border zone instigate an immune response 
that causes water and proteins to leak into in to the interstitial space through gaps in the 
endothelial cells linings of proximal vessels.76  Magnetic resonance imaging (MRI) has 
shown edema fluid swelling at the RFA site stabilizes over the first 10-12 min post-
ablation and not all edematous areas become chronic scar.79-81  Histological analysis and 
cellular damage markers confirm edema is present for several days post procedure.70, 76, 82  
Local edema subsides around 4 weeks post ablation, and permanent fibrotic scar is 
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complete formed several months after the initial ablation.70, 76  Figure 2 is a 
comprehensive timeline of the physiology of lesion RFA lesion development. 
Major complications can be caused by excessive RF-delivery during TCA and are 
reported in approximately 6% of RFA treated patients.4, 83, 84  For example, if the tissue is 
excessively heated (>100˚C) fluid evaporation can cause an interstitial pressure buildup 
that results in a steam “pop or rupturing of the myocardium.  Other serious morbidities 
caused by excessive RF-delivery include atrial esophageal fistulas, pulmonary vein 
stenosis, complete AV nodal block, and excessive damage to collateral tissue or coronary 
vessels.83, 85, 86 
 
 
Figure 1: Anatomy of a radiofrequency ablation lesion (RFAL). The 
radiofrequency ablation catheter (RFAC) is introduced to the right atrium (RA) 
through the inferior vena cava (IVC). The electrode tip is brought in contact with the 
endocardial (endo) surface.  As the RFAL forms, there are three distinct ablation 
zones: (1) thermocoagulated core caused by direct resistive heating, (2) irreversibly 
ablated zone caused by passive thermal heating, and (3) reversibly injured myocytes 
in hyperthermic “border zone” (~2 mm).  Myocardium more than 8 mm from the edge 
of the lesion (4) is unaffected by the RFA. Adapted from: 
http://www.hrsonline.org/Patient-Resources/Treatment/Catheter-Ablation#axzz2cvB7gaUy 
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Figure 2: Timeline of edema and chronic RFA lesions development. 
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2.3 Imaging and Guidance in Cardiac Ablation Procedures 
2.3.1 Fluoroscopy 
Fluoroscopy is a continuous X-ray imaging technique used to visualize catheter 
position and orientation in the body with high contrast.41  Unfortunately, fluoroscopy 
has poor contrast visualization of soft tissues and cannot provide visualization of the 
cardiac anatomy or RFA lesions.87, 88  Fluoroscopy also exposes the patient and medical 
personnel to ionizing radiation and should be used sparingly.   
2.3.2 Intracardiac Echocardiography (ICE) 
Intracardiac echocardiography (ICE), or catheter-based ultrasound, is performed 
with an 8 or 10 French catheter ultrasound probe and provides real-time visualization of 
the cardiac anatomy and function from within the cardiac chambers.89-92     
ICE is an indispensable tool for guiding safe and accurate transseptal punctures 
for LA access during PVI procedures; real-time ICE imaging locates the fossa ovalis in 
the atrial septum and monitors the transseptal needle puncture and sheath introduction 
across the septum to the LA.56, 89, 92, 93  The sheath is then used to feed procedural 
catheters (ablation and sensing) to the left side of the heart to perform the PVI.  The ICE 
catheter is also frequently introduced to the LA using a “sheathless” or double 
transseptal puncture.93, 94  ICE is also used to guide catheter placement and visually 
confirm RFA catheter-tissue contact for effective RF-delivery.   
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The real-time visualization and monitoring of potential procedural 
complications, such as pericardial effusions due to cardiac perforation, 
thromboembolism formation, atrioesophageal fistulas, or lesion steam pops is also done 
with ICE.41, 89   
While ICE serves a variety of important roles in complex ablation procedures, the 
acoustic contrast between ablated and unablated tissue is insufficient for lesion 
characterization.95, 96 
2.3.3 Electroanatomical Mapping Systems 
EAM systems, such as the CARTO systems (CARTO XP™ and CARTO 3™; 
Biosense Webster; Diamond Bar, CA), are the current clinical standard of practice for 
guiding RFA lesion placement during TCA.  EAM systems allow 1) tracking of 
procedural catheter tips in the heart without fluoroscopy, 2) construction of three-
dimensional (3-D) geometric cartoons of the cardiac chamber anatomy, 3) tagging of 
important procedure locations such as RFA sites, and 4) mapping of local electrical 
information onto the 3-D geometries for large scale understanding of the arrhythmia 
substrate and the post RFA chamber conduction.4, 41, 69, 97   
The CARTO systems use magnetic tracking to triangulate the 3-D positions of 
specialized mapping-ablation (NaviStar™; Biosense Webster, Inc., Diamond Bar, CA) 
and ultrasound (SoundStar™; Biosense Webster, Inc., Diamond Bar, CA) catheter tips in 
the heart to within 1 mm.97 
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A 3-D cartoon of the cardiac chamber is constructed by maneuvering the 
mapping catheter to multiple locations along the endocardial walls and plotting the 
relative tip positions.  Important locations, such as RFA delivery positions, are saved 
and displayed on the 3-D geometry.  The mapping catheter electrode-tip also collects 
local EG and calculates local activation times (LAT) relative to a reference EG or the 
ECG; the LAT are plotted on the 3-D volume to identify arrhythmogenic pathways and 
confirm electrical block post ablation.  The reference EG is often a separate sensing and 
pacing catheter that is positioned in the coronary sinus (CS).  Additional information 
about the CARTO XP™ system is provided in appendix A. 
Despite these important functions, EAM tracking systems can only indirectly 
infer RFA treatment from sparse electrical data and cannot provide direct visualization 
of RFA lesions.  The RFA point markers on the 3-D geometry represent RF-delivery 
locations, but do not characterize lesion size or transmurality. 
2.3.4 MRI for Substrate Characterization and RFA Assessment 
MRI (primarily T2-weighted and late gadolinium enhanced) is currently being 
vetted for pre and post-TCA substrate characterization and RFA lesions assessment 
during TCA.92, 98-104  MRI has proven to be a gold-standard for fibrosis substrate mapping 
and provides a non-invasive method to visualize ablation lesion patterns.105-107  While a 
promising pre and post-procedure substrate and lesion assessment tool, MRI has major 
limitations when translating to an intraprocedure imaging modality, such as the 
 20 
requirement of non-metallic procedural catheters and lengthy acquisition times.  
Specialized MRI suites are also expensive to build, equip, and run.  In addition, recent 
studies have shown MRI assessment of atrial RFA lesions has limited accuracy; MRI 
requires further investigation to prove it has adequate resolution for distinguishing 
unablated gaps in atrial lesion lines and adequate contrast sensitivity to distinguish 
transient interstitial edema from tissue necrosis.102, 104, 108  
2.4 Acoustic Radiation Force Impulse (ARFI) Imaging    
Acoustic radiation force impulse (ARFI) imaging is an ultrasound-based imaging 
technique that was recently developed at Duke University.  This section describes the 
concepts and methods behind the implementation of ARFI imaging as well as 
preliminary work for imaging of cardiac RFA lesions. 
2.4.1 Acoustic Radiation Force 
Acoustic radiation force is a body force generated by a transfer of momentum 
from an acoustic impulse wave into the target medium.109, 110  At ultrasonic frequencies 
the acoustic wave propagates as a plane wave and targeted soft tissue medium behaves 
as an incompressible, linearly viscous fluid.109, 111, 112  The force magnitude generated by 
the propagating wave is approximated by the following relationship: 
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F is the acoustic radiation force magnitude (units kg/s2·cm2), Wabsorb is the power absorbed 
by the tissue at a given spatial location (units W/100·cm3), and c is the speed of sound in 
the tissue (approximated as 1540 m/s).25, 65, 110  The absorbed power is equal to twice the 
attenuation-absorption coefficient of the tissue (α ≈ 0.55 dB/cm/MHz ) times the 
temporal average intensity I (units W/cm2) at the impulse location.113   
In soft tissue the majority of the energy from the ARFI-excitation or “push” is 
absorbed at the impulse focal region, and this spatially localized (1-8 mm3) energy 
generates a radiation force that deforms the tissue in the direction of the impulse 
propagation.22  The magnitude of the deformation is largest at the focal depth and is 
related to the stiffness of tissue.114, 115  The acoustic impulse length required to generate 
detectable axial displacements (on the order of microns, µm) in soft tissue is typically 
between 0.30 and 1 ms.116 
2.4.2 ARFI Imaging 
ARFI imaging is a novel imaging modality that has been refined into a unique 
clinical tool over the last two decades.26, 117  Radiation force elastography methods such 
as ARFI imaging have been increasingly investigated for the visualization of stiffness 
changes at RF ablation sites in the liver, kidney, and heart.29, 31, 32, 95, 96, 118-122 
ARFI images are formed by applying a coordinated sequence of radiation force 
impulses to soft tissue and temporally and spatially monitoring the resulting axial 
deformation with conventional ultrasound scan-lines.  The magnitude of the tissue 
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displacement is calculated using delay estimator methods such as normalized cross-
correlation or phase-shift autocorrelation.23, 123, 124  The measured ARFI-induced 
displacement is inversely proportional to the tissue stiffness and directly proportional to 
acoustic attenuation.25, 125-127  2-D ARFI images are formed by spatially distributing the 
ARFI excitations across a lateral FOV and assigning a color scale to the measured 
displacements for visualization of the relative tissue stiffness. 
ARFI imaging is currently implemented from software-modified diagnostic 
ultrasound scanners and uses conventional ultrasound transducers for the generation of 
the radiation force and the tracking of the tissue response.  The use of traditional 
diagnostic equipment also provides the ability to acquire spatially and temporally co-
registered traditional B-mode images.  
Due to the assortment of ARFI imaging sequences, ultrasound scanners, and 
transducers used in this thesis, the specific imaging and sequencing parameters for each 
experiment are described in the methods section of each chapter. 
2.4.2.1 Cardiac Motion and ARFI imaging  
The maximum LA wall velocity is approximately 3.2 cm/s in the normal human 
heart.128, 129  In elderly patients or in patients diagnosed with a cardiac arrhythmia this 
velocity could be higher.  Motion of this magnitude can overwhelm the ARFI-induced 
displacement magnitude as well as cause decorrelation of the tracking scan-lines, 
thereby increasing the bias (mean of the displacement error) and jitter (error of the bias, 
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or standard deviation of the displacement error) of the displacement estimation.23, 130  
Specialized processing methods are used for cardiac ARFI imaging to separate the 
displacements generated by the ARFI-excitation from the bulk physiologic motion.96, 130-
132  These motion filtering methods estimate the bulk physiological motion by fitting a 
quadratic curve to the measured displacement profile at each pixel in the image.  The 
estimated motion function is then subtracted from the measured displacements to 
recover the ARFI-induced displacement. 
Two methods for constructing the motion curve fit are used in the thesis: 1) 
interpolation of the motion function from the pre-excitation position and a post ARFI-
excitation position and 2) extrapolation of the motion function using the pre-excitation 
baseline motion to approximate the motion profile.130  Basic motion filtering has been 
shown to reduce motion artifacts to under 1 μm over the cardiac cycle.96 
2.4.2.2 Image Quality 
In this thesis, image quality is quantified by calculating RFA lesion contrast (C) 
and contrast-to-noise ratio (CNR).  C and CNR are calculated using equations 7 and 8, 
where μO and μL are the mean signal inside the lesion and outside the lesion 
respectively, and σO2 and σL2 are the variances. 
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2.4.3 Preliminary Work on ARFI Imaging of RFA Lesions 
Several studies investigating the feasibility of cardiac RFA lesion visualization 
with ARFI imaging have been conducted.31, 32, 95, 96, 133  This section describes the studies 
that laid the groundwork for the research presented in this thesis. 
2.4.3.1 In vivo Feasibility 
Preliminary in vivo feasibility studies were conducted by Fahey et al. in 2005 and 
Hsu et al. in 2007.95, 96  Fahey et al. were the first to observe the localized stiffness change 
caused by cardiac RFA using ARFI imaging.95  Hsu et al. prepared this technology for 
potential clinical translation by developing ARFI imaging sequences for an intracardiac 
ultrasound transducer; in a canine model they observed an increase in tissue stiffness at 
three endocardial RFA sites, evident by a decrease in the measured ARFI-induced 
displacement.96  This work also described the challenges encountered when 
implementing ARFI imaging from an ICE catheter.96  It was discovered that the flexible 
transducer tip experienced a small rebound force from the generation of the ARFI-
excitations.  It was determined that the radiation force pulses transmit high intensity 
acoustic waves backwards into the transducer matching layer as well as forward into the 
tissue.  The absorption of this mechanical energy generated a force that bent the flexible 
imaging catheter in the opposite direction of the ARFI-excitation.  This transducer “kick-
back” was initially non-linear and tracked in the displacement estimations.  They 
prepared sequences that applied ten “priming pulses” before the 2-D ARFI imaging 
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sequence so any remaining kick-back motion was linear and could be effectively motion 
filtered from the ARFI displacement estimations.  This priming pulse technique is used 
in the ICE-based sequences developed for the experiments in this thesis. 
It has been shown that diastolic imaging is ideal for ARFI imaging of lesions in 
vivo because the contrast between the stiff RFA lesion and normal tissue decreases when 
the myocardium stiffens during systole.95, 96, 133  Also, late diastole is the time of least 
intrinsic motion during the cardiac cycle and reduces the effects of bulk cardiac motion 
on the tissue displacement measurements.  Figure 3A illustrates the relative stiffness 
difference between systole and diastole around a ventricular epicardial RFA lesion.133 
The lesion is visible as a semicircular region of relatively low ARFI-induced 
displacement (dark blue).  The ARFI image contrast between the lesion and unablated 
myocardium (red) is maximal during diastole (figures 3A-1 and 3A-4) 
All ARFI images presented in this thesis were ECG-gated to diastole.  The 
challenges associated with non ECG-gated ARFI image acquisitions, for example during 
AF, was beyond the scope of this thesis, but is briefly discussed in the future work 
section of chapter 7. 
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Figure 3: ARFI images of a right ventricular epicardial RFA lesion through the 
cardiac cycle. A non-irrigated electrode tip ablated the epicardial surface (EPI = 
epicardium, ENDO = endocardium) for 7 sec at 20 W. A) ARFI images acquired at 
different times during the cardiac cycle: (1) and (4) during diastole, (2) during systole, 
and (3) during end-systole. ARFI images were acquired with a linear transthoracic 
probe vacuum suctioned to the RV epicardium.  Color bar units are maximum 
displacement away from the transducer in microns. Within the lesion the ARFI 
induced displacement is low (blue) throughout the cycle.  The normal myocardium 
cycles between high displacement (red) during diastole and low displacement (blue) 
during systole.  B) ARFI acquisition times corresponding to the ECG. 
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2.4.3.2 In vitro Lesion Assessment 
The accuracy of determining RFA lesions size with ICE-based ARFI imaging was 
investigated in vitro in earlier work.31  This study determined that lesion dimensions 
from ARFI and pathology images were statistically similar and within 1-2 mm.   
An example lesion from this study is shown in figure 4.  The red spectrum of the 
ARFI-induced displacement color bar represents normal myocardium, while the region 
of lower induced displacement is represented by the blue-green portion of the color bar.  
The determined lesion traces correlate will with the RFA lesion pathology. 
 
 
 
Figure 4: ARFI imaging determined lesion boundaries.  The maximum ARFI-
induced displacement (left) and depth normalized (center) image were overlaid 
onto the photograph of the lesion cross-section.  The lesion boundary traces were 
determined by a manual (black) and automatic (blue: optimal, and green: 
standardized) segmentation of the digital image. 
 
Another experiment demonstrated ARFI imaging can visualize the RFA-induced 
myocardial stiffness increase during lesion formation in vitro.  Figure 5 shows the 
relative stiffness change in the myocardium that occurs during RFA.32 
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Figure 5: ARFI images acquired during an in vitro RFA.  (A) The pre-RFA 
image shows high ARFI-induced displacement throughout the myocardium.  During 
RFA a growing region of increased stiffness appeared (B-D). The plane of the RFA 
catheter is into the page and the effective depth of field (1.5 cm focus) is between 1.0 
and 2.25 cm.  (G) The mean and standard deviation of the ARFI displacements 
measured outside the lesion remained constant during RFA but decreased inside the 
lesion.  (H) The tissue was sliced in the approximate imaging plane and stained with 
triphenyltetrazolium chloride (TTC) to confirm a lesion was created. 
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Chapter 3:  Temporal-Spatial Monitoring of Acute 
Cardiac Radiofrequency Ablation Lesions with 
ARFI imaging In Vivo 
 
The work described in this chapter will be submitted for publication in the following 
manuscript: 
 
Eyerly SA, Dumont DM, Trahey GE, Wolf PD.  Temporal-Spatial Monitoring of Acute Cardiac 
Radiofrequency Ablation Lesions with Acoustic Radiation Force Impulse Imaging In Vivo. 
 
3.1 Introduction 
Previous work has shown ARFI imaging can characterize RFA lesions in vitro, 
but RF-delivery in living tissue induces transient physiological processes (see section 
2.2.2) that may affect the stiffness at the RFA site.  Immediate post ablation lesion 
monitoring with ARFI imaging and could improve our understanding of acute RFA 
lesion formation and the stability of the tissue necrosis.  This chapter investigates the in 
vivo temporal-spatial stability of acute RFA lesions evaluated with ARFI imaging. 
This study utilized a linear array transducer suctioned directly to the cardiac 
wall to monitor endocardial lesion formation and post ablation lesion stabilization.  The 
aims of this investigation were 1) to evaluate the contrast and stability of the ARFI-
induced displacement measurements in regions of interest (ROI) inside the RFA lesion, 
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in the border zone, and outside the lesion and 2) to characterize any changes in lesion 
area over a 30 minute monitoring period immediately post ablation.   
The chapter is organized as follows: section 3.2 describes the experimental 
protocol and ARFI imaging methods for repeatable imaging of acute RFA lesions sites.  
Section 3.3 describes the experimental results, and section 3.4 discusses the implications 
of these findings for implementation of in vivo ARFI imaging and the relevance to 
clinical translation. 
3.2 Methods  
3.2.1 Animal Experimental Protocol 
The animal experimental protocol described in this study was approved by the 
Duke University Animal Care and Use Committee and conformed to the Guide for the 
Care and Use of Laboratory animals.134 
Six canine subjects were anesthetized (pre-anesthesia: intramuscular 
acepromazine 0.02-0.05 mg/kg followed by interveinous propofol 4-6 mg/kg; general 
anesthesia: isoflurane gas 1-5% via inhalation), intubated, ventilated, and maintained 
metabolically stable.  A thoracotomy was performed and the pericardium was opened 
and sutured to form a cradle, exposing the epicardium of the heart.  A VF10-5 linear 
ultrasound transducer (Siemens Healthcare; Issaquah WA) was put into a vacuum-
coupling device and positioned over the right ventricular (RV) epicardium using an 
adjustable stabilization arm mount. The vacuum-coupling device suctioned directly to 
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the epicardium to maintain the imaging position.  The vacuum apparatus also held the 
transducer ~1 cm from the heart (imaging through an ultrasonically transparent 
standoff) to position the imaging focus in the center of the myocardium (figure 6).  
 
 
 
Figure 6: Open chest in vivo ARFI imaging experimental setup.  The VF10-5 
ultrasound transducer (UT) was held by a vacuum-coupling apparatus (VA) and 
positioned directly onto the right ventricular free wall (RVFW) using an adjustable 
stabilization arm (SA).  The ablation catheter (AC) was introduced to the heart 
through the inferior vena cava (IVC) and brought in contact with the RVFW 
endocardium directly under the UT.  The RFA lesion (L) formed in the ARFI imaging 
plane. 
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ARFI images were acquired before, during, and approximately every 30 to 45 
seconds for 30 minutes after a 60 second temperature-controlled (65°C) endocardial 
ablation with the RFA catheter (7 Fr, Celsius™: Biosense Webster, Diamond Bar, CA) in 
the ARFI imaging FOV.  All ARFI acquisitions were ECG-gated to diastole to maximize 
the stiffness contrast between the RFA lesion and surrounding myocardium, as well as 
minimize the cardiac motion during the acquisition.133  Respiration was held during 
imaging to minimize the effects of respiratory motion on the image plane position.   
At the end of the study, the canine was euthanized and the heart was removed.  
Each lesion (1-3 per canine) was manually cross-sectioned (~1 mm slices) parallel to the 
approximate imaging plane used during the procedure.  The tissue samples were 
stained with triphenyltetrazolium (TTC) and photographed.  
3.2.2 ARFI Imaging Methods and Image Processing 
Co-registered ARFI and B-mode imaging was performed with a hardware and 
software modified Siemens SONOLINE Antares™ ultrasound scanner and an 
unmodified 192 element VF10-5 linear ultrasound transducer (Siemens Healthcare; 
Issaquah, WA).  Each ARFI image sequence completed in 110 ms, and the raw data was 
saved as in-phase and quadrature demodulated (IQ) data by the ultrasound scanner. 
All images were formed with a center frequency of 8.0 MHz and an ARFI-
excitation frequency of 5.7 MHz.  The ARFI images were acquired with a focal depth of 
1.6 cm or 2.0 cm.  For each acquisition, 36 radiation force impulses (53 μs pulse length) 
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were delivered at equally spaced locations over a 2.14 cm lateral FOV.  At each lateral 
location, eight ultrasound pulses (~10 kHz tracking pulse reputation frequency, PRF) 
were transmitted before the ARFI-excitation to determine the initial position of the 
tissue, and fifteen were transmitted after the excitation to monitor the ARFI-induced 
tissue deformation.  Four-to-one parallel-receive imaging (4:1, four echo lines received 
for each transmit pulse) was used to increase the line density of the ARFI image.135  The 
final ARFI image had a line density of 67 lines per cm.  The ARFI imaging parameters 
are summarized in table 3. 
 
Table 3: ARFI imaging parameters for the VF10-5 linear transducer. 
Transducer Probe VF10-5 
 Elements 192 
 Array Type Linear 
 Center Frequency [MHz] 5.71 
Scanner Model (Siemens) Antares™ (SONOLINE) 
Data Type IQ 
B-mode  
and  
ARFI 
Imaging 
Parameters 
Transmit Frequency [MHz] 5.71 
Tracking Frequency [MHz] 8.00 
Sampling Frequency [MHz] 40 
Focus [cm] 1.6 or 2.0 
F/# 2.4 or 3.0 
Cycles 300 
ARFI-excitation length [µs] 53 
ARFI-excitation lateral locations 36 
Parallel tracking 4:1 
Pre-tracks 8 
Post-tracks 15 
Tracking PRF [kHz] 10 
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Figure 7: ARFI-induced displacement curve for a single pixel in the 
myocardium.  Eight scan-lines were acquired before the excitation to determine the 
baseline position.  The motion filter function (blue) was extrapolated from the pre-
excitation data, and subtracted from the raw displacements (triangles) to calculate the 
motion filtered displacement profile (circles).  Fifteen scan-lines were acquired after 
the ARFI-excitation to monitor the axial tissue displacement.  Total tracking time for a 
single line was ~2.75 ms.  The maximum displacement over the tracking time 
(magenta star) was the pixel value in the 2-D ARFI image.  
 
The ARFI-induced axial displacement magnitudes were calculated by correlating 
each post-excitation track-line with the echo from the last reference line using a phase-
shift estimation algorithm (Loupas, axial kernel: 1.5λ, wavelength).23, 124  A quadratic 
extrapolation motion filter technique was used to minimize the effects of bulk axial 
motion on the estimated displacements.24, 136, 137  An example of this process for a single 
pixel location is presented in figure 7.   
 35 
The quality of the displacement estimation for each pixel-kernel location was 
quantified by calculating the magnitude of the complex correlation coefficient (CXCC) 
calculated during the phase-shift estimation.117, 138  Pixel locations with low CXCC, such 
as in the blood, exhibited significant decorrelation of the signals between the tracking 
lines.  Any pixel where the median CXCC through the tracking time was below 0.90 was 
removed from the final ARFI image.  Displacements measured in the blood also had 
large standard deviations; any pixel with a standard deviation larger than 20 µm was 
also removed. 
3.2.3 Temporal Image Registration and ARFI Image Normalization 
 The vacuum apparatus and arm mount stabilized the position of the transducer, 
but the dynamic motion of the heart and lungs inevitably caused small translations of 
the imaging plane between image acquisitions.  A 2-D normalized cross-correlation 
registration of the B-mode images was performed to compensate for any small axial or 
lateral translations of the imaging plane through the time-course.  The ARFI images 
were not involved in the registration process. 
 The image templates for the correlation were automatically chosen as 1 mm 
above the highest point of the epicardium and 1 mm below the lowest point of the 
endocardium for all the images in the lesion time-course.  The epicardium and 
endocardium were automatically determined as the edges of the myocardium in the 
thresholded B-mode image.  The applied threshold was the brightness intensity mean in 
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each image plus 0.8 (epicardium) or 0.45 (endocardium) of the standard deviation.  The 
region containing the myocardium was manually segmented before the thresholding to 
mask the ablation catheter and far-field cardiac structures.  The detected endocardium 
and epicardium were smoothed using an eight pixel median filter.   
 Each image was correlated with all the other images from the time-course.  The 
maximum spatial correlation coefficient for the pair was used as a registration qualifier 
(RQ) to quantify the overall quality of the image registration. 
 
 
Figure 8: Block diagram of B-mode image spatial registration. 
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 The post ablation image with the highest RQ sum for all image combinations was 
used as the reference image for the spatial registration (axial and lateral translation) of 
the other images.  Individual images with a RQ lower than 0.65 were discarded from the 
statistical analysis.  The registration process is summarized as a block diagram in figure 
8.  Occasionally air bubbles would become trapped between the transducer and 
myocardium; images where an air bubble created noisy artifacts in the myocardium 
were also removed from analysis. 
The maximum ARFI-induced displacements were normalized to minimize the 
effects of the focal depth of field (DOF) and energy attenuation.31, 139   The pre-ablation 
image with the highest RQ sum for all correlation combinations was used for the ARFI 
image normalization.  In this image, the maximum measured ARFI-induced 
displacements in the myocardium (0.5 mm below the epicardial surface and 0.5 mm 
above the endocardial surface) were laterally averaged across FOV and plotted as a 
function of axial depth.  A quadratic curve was fit to this plot and the resulting function 
was used to normalize each displacement pixel as a function of depth. 
3.2.4 Contrast Analysis and Temporal Stability of Normalized 
Displacements 
For all post ablation images, the RFA lesion was automatically detected by 
thresholding (mean normalized displacement in the myocardium minus one third of the 
standard deviation) the normalized ARFI-induced displacements.  A composite lesion 
for each lesion group was defined by combining pixel locations that were classified as 
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lesion in at least 75% of the post ablation images.  Three 1x1 mm regions of interest 
(ROI) were automatically defined for each lesion group using the composite lesion: 1) 
the lesion interior (lesion centroid), 2) the lesion border zone (lesion edge at axial depth 
of centroid), and 3) 3 mm outside lesion border zone (at axial depth of centroid). A 
repeated measures analysis of variance (ANOVA) was performed to test the significance 
of the variance between individual lesion and the effects of RFA (inside vs. outside) on 
the mean normalized displacement in the ROI.  
The means of the ROI in each lesion group were plotted versus time to examine 
the stability of the normalized measurements.  An exponential curve fit (equation 9) was 
used to find the stabilization time of the normalized ARFI displacements in the lesion 
interior and border zone ROI, where t (units, seconds) is time, dFinal is the final 
displacement, dInitial is the initial displacement from the last pre-ablation frame (t = 0 
seconds), and τ (units, 1/seconds) is the stabilization time constant.   
 
                                
           (9) 
 
The time to stabilization was approximated as three times the time constant, or when 
~95% of the steady-state was reached. 
 The C and CNR of the RFA lesion were calculated using the maximum ARFI-
induced displacements and B-mode signal intensities from the ROI from inside and 
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outside the lesion.  A one-tailed t-test was performed to confirm an improvement in C 
and CNR in the ARFI images compared to the B-mode images. 
3.2.5 Temporal Stability of Lesion Width and Area 
The TTC stained lesion cross-section at the approximate imaging location was 
examined to compare the final lesion morphology and transmurality. 
For each lesion, the normalized ARFI-induced displacements across the lateral 
FOV at the axial depth dictated by the lesion centroid were compiled in an image and 
plotted through the time-course to visually examine the stability of the lesion width. 
The area of the lesion in each ARFI image was determined by thresholding 
(mean of displacements in border zone ROI) the normalized displacements and finding 
the filled area around the composite lesion centroid.  For lesions at the edge of the FOV, 
the area calculation was bounded by the maximum lateral shift of the images through 
the time-course.  The detected lesion area was plotted against time, and the approximate 
stabilization time was calculated using the exponential fit method described in the 
previous section. 
3.3 Results  
A total of 12 lesions were made in six canine subjects.  Full analysis was 
completed for seven lesions; the five unreported lesions had a substantial number of 
frames removed (low RQ) during the registration analysis, and either had no ARFI 
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images within five minutes of the ablation (three) or no images past 20 minutes (two).  
The means and ranges of the RQ for the seven reported lesions are shown in table 4. 
Figure 9 and 10 show B-mode, ARFI, and pathology images for two lesions 
before, during and after RFA lesion formation.  The ablation catheter remained in place 
through the time-course (‘stiff’ (blue) region with artifact below). During RFA, the 
normalized ARFI-induced displacements in the myocardium decreased radially from 
the ablation catheter contact (ACC) point, forming a stiff semicircular lesion.  Post RFA, 
ARFI imaging showed consistent lesion stiffness and morphology through the time-
course.  In figure 9, the thermocoagulated core was the stiffer (dark blue) in the ARFI 
images than the lesion border zone (light blue-yellow), identifiable as the less intensely 
stained brownish-pink rim around the lesion in the pathology image.  All lesions that 
appeared transmural in the ARFI images were confirmed as transmural in the pathology 
images. 
 
Table 4: Registration analysis of B-mode images. 
 Post Ablation Images 
Lesion N 
Mean  
RQ 
RQ 
Range 
A 34 0.88±0.06 0.741 – 0.976 
B 48 0.83±0.09 0.662 – 0.952  
C 33 0.81±0.12 0.656 – 0.980  
D 46 0.85±0.11 0.657 – 0.978 
E 48 0.85±0.08 0.668 – 0.973 
F 45 0.81±0.09 0.650 – 0.966 
G 33 0.87±0.08 0.678 – 0.976 
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Figure 9: B-mode (left column), ARFI (center column), and pathology (right 
column) images for RFA lesions formation (lesion C).  Before ablation, the normalized 
ARFI-induced displacements are homogeneous in the myocardium (red).  During 
RFA, a semi-circular region of lower displacement (blue) grows from the ablation 
catheter contact point on the endocardium. The lesion size did not change 
significantly during the monitoring time-course and is comparable to the morphology 
in the TTC stained tissue pathology image at the approximate imaging plane. 
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Figure 10: B-mode (left column), ARFI (center column), and pathology (right 
column) images for RFA lesions formation (lesion A).  Before ablation, the 
normalized ARFI-induced displacements are homogeneous in the myocardium (red).  
During RFA, a semi-circular region of lower displacement (blue) grows from the 
ablation catheter contact point on the endocardium (slightly out of plane immediately 
after RFA).  The lesion size did not change significantly during the monitoring time-
course and is comparable to the morphology in the TTC stained tissue pathology 
image at the approximate imaging plane. 
 43 
Overall, the lesion morphology and transmurality observed in the pathology 
images were consistent with the lesion morphology seen in the ARFI images.   
3.3.1 Temporal Stability and Image Contrast Analysis 
Figure 12 shows the post ablation reference B-mode images, ARFI images, and 
outlined ROI for five lesions.  Figure 11 presents plots of the mean normalized ARFI-
induced displacements and stabilization curve fits for the ROI inside, at the border zone, 
and outside the lesions.  For all post ablation image ROI (n = 287), the mean normalized 
displacement values were 0.21±0.06, 0.59±0.12, and 0.90±0.15 respectively.  An ANOVA 
determined RFA lesion had a significant (p << 0.001) effect on the normalized 
displacement means, while the individual lesion did not (p = 0.425). 
 
 
Figure 11: Means of the normalized displacement for the ROI inside the lesion 
(left), in the lesion border zone (center), and outside the lesion (right) and exponential 
stabilization curve fits (solid lines).  Inside the lesion the normalized displacements 
reach maximum stiffness within the first two minutes post ablation. In the lesion 
border zone, the normalized displacements stabilized over the first several minutes 
post ablation. While showing variability over a narrow range, there was no significant 
change in the normalized displacements outside the lesion. 
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Figure 12:  Reference B-mode (right column) and ARFI images (center column) 
of RV endocardial RFA lesions (lesion groups A, B, C, E, and G).  White boxes outline 
1x1 mm ROI inside the lesion, in the lesion border zone, and outside the lesion.  The 
displacements at the axial depth delineated by the horizontal white line are plotted 
for each ARFI image through the time-course (30 second wide bars) to observe the 
spatial stability of the lesion (right column).  The black region represents the 
temporal gaps or the lateral translation of each ARFI image based on the registration 
analysis.  The ablation occurred between 0 and 60 seconds (white vertical lines). The 
lesion widths appear consistent through the time-course. 
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Table 5: Normalized displacement stabilization times and contrast analysis of ARFI 
and B-mode images of RFA lesions. 
Lesion 
Group 
Stabilization Time (sec) RFA Lesion Contrast Analysis* 
Lesion 
Center 
Border 
Zone 
Lesion 
Area 
ARFI 
C 
ARFI 
CNR 
B-mode 
C 
B-mode 
CNR 
A 60 689 255 0.73±0.02 6.3±0.83 0.004±0.10 0.16±0.08 
B 11 394 88 0.77±0.01 5.1±0.68 -0.17±0.10 0.28±0.15 
C 69 737 109 0.85±0.01 6.4±0.97 -0.25±0.06 0.43±0.09 
D 6 123 91 0.74±0.05 2.5±0.38 -0.32±0.16 0.49±0.17 
E 107 297 120 0.71±0.01 4.8±0.73 -0.11±0.06 0.19±0.10 
F
†
 - - - 0.70±0.02 3.2±0.63 0.15±0.06 0.31±0.12 
G 302 575 463 0.89±0.01 3.5±0.94 -0.27±0.13 0.40±0.19 
Mean 92±109 469±239 188±149 0.77±0.07 4.5±1.52 -0.14±0.17 0.33±0.12 
* Right-tailed paired t-test for C (p = 8.9e-9) and CNR (p = 4.8e-6) between ARFI and B-mode images. 
† Lesion F:  pre-ablation and lesion formation image occurred at different imaging position than the remainder of the 
time-course due to a large elevation shift of the transducer shift immediately following ablation. 
 
The normalized displacement stabilization time and results of the contrast 
analysis are presented in table 5.  A one-tailed paired t-test determined the mean C and 
CNR were significantly higher in the ARFI images than the B-mode images. 
3.3.2 Temporal Stability of Lesion Width and Area 
The compiled normalized ARFI-induced displacements for single axial location 
(axial depth delineated by white horizontal line) through the time-course is shown in 
figure 12.  The locations of the lesion borders displayed temporal stability. 
Figure 13 plots the detected lesion area and stabilization curve fits for each of the 
seven lesions.  In all lesions, the detected area grows rapidly during RFA and stabilizes 
within the times presented in table 5.  The mean increase in lesion area was 11.2±7.2% 
between the first post ablation image and the last (range 2.7-24.4%), and the lesion area 
stabilized within ~2 minutes of the ablation. 
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Figure 13: Time-course of RFA lesion area as detected by ARFI imaging.  RF-
energy delivery commenced at 0 sec and was terminated after 60 sec (black vertical 
line).  Exponential stabilization curve fits are plotted as solid lines. 
 
3.4 Discussion and Conclusions 
This chapter described a method for monitoring cardiac RFA lesion formation in 
vivo and as well as the spatial and temporal stability of the lesion with ARFI imaging.  
The results showed ARFI imaging can successfully identify acute stiffness changes in 
RFA treated myocardium in vivo with good repeatability and high image contrast.  
ARFI imaging measured a significant reduction in normalized ARFI-induced 
displacements in RFA lesion, and the normalized displacements in the lesion center 
stabilized within the first minute post ablation.  The normalized displacements in the 
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border zones were stable within 10 minutes.  The detected lesion area stabilized 
approximately 2 minutes after ablation, and the mean change in area over the post 
ablation monitoring time for all lesions was ~11% and no more that 25% for any 
individual lesion.   
Tissue cooling following RF-delivery is not instantaneous; the myocardial 
temperature at RFA sites has been shown to remain in the hyperthermic injury range for 
almost a minute post ablation until convective cooling and tissue perfusion return the 
tissue temperature to baseline.140-142  The 1-2 minute stabilization times for the lesion 
center and lesion area were consistent with this observation.  The measurements of the 
relative tissue stiffness were stable through the remaining time-course. 
3.4.1 Implications for Clinical Lesion Assessment 
3.4.1.1 Edema at the RFA site 
Lardo et al. conducted a comprehensive assessment of the temporal and spatial 
stability of RFA lesions in canine RV with MRI (T2 weighted fast-spin echo).  This study 
found the lesion image intensity increased and plateaued after the first 10-12 min post 
ablation (temporal resolution of 2 minutes) once the hydrostatic pressure and edema 
infiltration equilibrated.79  This study also showed the MRI imaged lesion size stabilized 
in the first 5-6 min of lesion formation and slightly overestimated the size of the lesion 
when compared to a histological cross-section of the tissue.  
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In this chapter, the detected lesion area based on the ARFI measured relative 
stiffness stabilized in the first 1-2 min after RF-delivery; therefore the ARFI imaging 
evaluation of tissue damage based on the stiffness changes at the ablation site stabilized 
faster than the MRI visualized changes in water content which was largely affected by 
edema.  This finding suggests that the measured ARFI-induced displacements were not 
significantly confounded by any increase in the interstitial tissue pressure caused by 
edema around the ablation site. 
3.4.1.1 Necrosis at the Lesion Boundary 
It has also been shown that actin-myosin contraction band necrosis can be 
present around the edge of RFA lesions in vivo.99, 143, 144  Possible mechanisms for the 
appearance of these bands are: 1) local ischemia due to decreased perfusion at the 
ablation site, or 2) a heat-induced rise in myocyte calcium influx that causes 
hypercontraction and cell death due to cytosolic calcium overload.43, 145, 146  Studies have 
shown lesions composed of high concentrations of these bands appear in canine 
myocardium within 6 to 10 minutes of exposure to cardiotoxic doses of isoproterenol.  
The spatial and temporal formation of these bands during RF ablation has yet to be 
characterized.146-148  It also remains unclear whether all contraction band necrosis 
becomes chronic scar.143, 149  Edema accumulation from ruptured cells and micro-vessels 
has also been observed in areas of contraction band necrosis.144   
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In this study, this banded zone (incomplete thermocoagulation) at the lesion 
boundaries was presumably stained lighter pink in the TTC pathology images; the 
relative stiffness gradient (light blue-yellow spectrum, see figure 9) observed at the RFA 
lesion edge in the ARFI images often showed similar morphology to this boundary in 
the pathology images.  Also, the longer and highly variable relative stiffness 
stabilization times for the border zone ROI likely reflected the spatial density and 
dynamic stiffening of the contraction bands and associated edema.  A stiffening of these 
areas, as opposed to “growth” of the lesion, is consistent with the finding that the lesion 
width and area were stable within minutes post-ablation.  Due to the ambiguity of 
determining myocyte death this region, in a clinical setting ablating the tissue to the blue 
spectrum (> ~30% of pre-ablation ARFI-induced displacement) of the ARFI imaging 
color scale would ensure complete RF ablation. 
Overall, a better understanding of the connection between acute lesion 
compliance (protein coagulation, contraction band necrosis, and edema) and the degree 
of electrical damage could provide a method to distinguish viable or electrically 
“stunned” tissue from complete thermocoagulation and unablated myocardium.  
Elasticity-based evaluation of RFA lesion could also potentially provide a method to 
optimize the RF-energy delivery and avoid complications associated with excess 
delivery of RF-energy. 
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3.4.2 Study Design and Limitations 
The exact experimental setup described in this study is not a clinically executable 
method.  Given the study objectives, this experimental method was used because it 1) 
maximized the stability of the imaging plane during the ablation and time-course 
monitoring, 2) minimized any interference from the RF-energy application because ICE 
catheter transducers are unshielded and experience interference in the ultrasound signal 
when RF-energy is applied, and 3) maximized the ARFI imaging FOV. 
A direct comparison between the ARFI imaging determined lesion area and the 
stained lesion pathology was not done in this experiment due to the likelihood of large 
misregistration errors between the pathology cross-section and the actual imaging plane.  
Moreover, several lesions were imaged at the edge of the FOV; attempting to spatially 
align the edges of the imaging plane to the pathology image would also have created 
errors in the area measurements.  Despite any misregistration of the pathological lesion 
cross-sections, it was valuable to observe and compare the lesion morphology and 
transmurality to the ARFI image. 
The stability of the imaging plane was the primary cause of variation and error in 
this study.  The 2-D normalized cross-correlation was able to adjust for axial and lateral 
shifts of the imaging plane, but was unable to correct for any elevation or angular 
translation.  Slight changes in the imaging location may have resulted in the imaging of 
a completely different cross-section of the lesion.  Changes in the heart rate may also 
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have caused temporal variation in the ARFI images.  The diastolic delay was held 
constant over the time-course and variations in the heart rate would acquire a slightly 
different point in the cardiac cycle.  Regardless, any instability of the imaging planes did 
not appear to affect the findings of this study. 
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Chapter 4:  Integration of ARFI Imaging and 
Electroanatomical Mapping for Intraprocedure 
Intracardiac Radiofrequency Ablation Lesion 
Assessment 
 
The work described in this chapter is under review for publication in Ultrasonic 
Imaging: 
 
Eyerly SA, Bahnson TD, Koontz JI, Bradway DP, Dumont DM, Trahey GE, Wolf PD.  Contrast 
in intracardiac acoustic radiation force impulse images of radiofrequency ablation lesions. 
 
4.1 Introduction 
In chapter 3, a method for acquiring high contrast ARFI images of RFA lesions in 
an in vivo open chest setup was described.  While a successful experiment for precisely 
monitoring lesion formation and temporal-spatial stability, clinical TCA procedures are 
conducted in a closed environment with catheters; the use of a linear transducer to 
directly image the heart during clinical ablation procedures is not feasible. 
Real-time ICE has become an important tool for imaging cardiac anatomy and 
ablation catheter-myocardium contact during clinical TCA procedures.  Intracardiac 
ARFI imaging sequences were developed for the standard ICE transducer often used in 
TCA cases.   
Unlike real-time ICE imaging, 2-D ARFI imaging requires a diastolic gated 50-
100 ms acquisition time which limits the display update time interval to the order of 
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seconds.  This frame rate makes it difficult to “scan” the heart for lesions during a TCA 
procedure.  ARFI imaging from an ICE transducer also limits the FOV, as wide beam 
steering angles have shown a substantial decrease in the ARFI-excitation energy and the 
resulting displacements.96  Therefore, a method for using EAM to precisely guide the 
ARFI imaging plane to RFA lesion sites during TCA was established.  Background 
information about the CARTO EAM system is provided in appendix A. 
The first objective of this chapter was to verify the integration of a multi-
modality ARFI imaging-EAM system for efficient intraprocedure ARFI imaging of RFA 
lesions.  With this system, the ARFI imaging plane could be navigated to RFA delivery 
locations marked in the electroanatomical map, and the EAM system RFA markers were 
treated as positive indicators for the presence of RFA lesions.  This multi-modality 
system was then used to 1) determine the accuracy of identifying RFA lesion delivery 
locations in electroanatomical maps with ARFI images, 2) quantify the typical ARFI-
induced displacement ranges achieved by the ICE transducer in RFA lesion and 
unablated myocardium, and 3) calculate and compare the C and CNR between RFA 
lesion and unablated myocardium for ARFI and conventional ICE images. 
The chapter is organized as follows:  Section 4.2 describes the ARFI imaging-
EAM system integration as well as the animal experimental protocols to verify the 
system and assess linear RFA with intraprocedure ICE-based ARFI imaging.   Section 4.3 
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describes the results from the system verification and linear RFA experiment, and 
section 4.4 discusses the findings and the utility of the integrated system. 
4.2 Methods 
The animal study protocol executed in this chapter was approved by the Duke 
University Animal Care and Use Committee and conformed to the Guide for the Care 
and Use of Laboratory animals.16   
All canine subjects were anesthetized (pre-anesthesia: intramuscular 
acepromazine 0.02-0.05 mg/kg followed by interveinous propofol 4-6 mg/kg; general 
anesthesia: isoflurane gas 1-5% via inhalation), intubated, ventilated and maintained 
metabolically stable.  
4.2.1 Multi-Modality Imaging System 
4.2.1.1 ARFI Imaging Sequences and Image Processing 
An ACUSON S2000™ ultrasound scanner (Siemens Healthcare, Issaquah, WA, 
USA) was software modified to implement 2-D ARFI beam sequences from a standard 
64 element SoundStar™ catheter phased-array (Biosense Webster, Diamond Bar, CA, 
USA).  Images were acquired with transmit and receive center frequencies of 6.15 MHz 
and with a 1.5 cm focus (F/# = 2.14).  The imaging parameters are summarized in table 6. 
The first part of the imaging sequence consisted of a 90˚ B-mode image.  Next, 
ten high intensity ARFI priming-pulses were transmitted to linearize the transducer 
kick-back so it could be easily filtered from the ARFI-induced displacement profiles (see 
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section 2.4.3.1).96  The next step in the imaging sequence was to acquire a 2-D (~54˚ FOV) 
ARFI image consisting of 42 equispaced spatially-interleaved (wiper-bladed) ARFI 
locations.  Each lateral ARFI-excitation location was interrogated with 8 scan-lines 
before the excitation at a tracking PRF of 9.7 kHz.   
 
Table 6: 2-D ICE-based ARFI imaging parameters. 
Transducer Probe SoundStar™ (10 French) 
 Elements 64 (7 mm length) 
 Array Type Phased 
 Center Frequency [MHz] 6.15 
Scanner Model (Siemens) S2000™ (ACUSON) 
Data Type RF 
B-mode  
and  
ARFI 
Imaging 
Parameters 
Transmit/Tracking Frequency [MHz] 6.15 
Sampling Frequency [MHz] 40 
Focus 1.5 cm 
F/# 2.14 
Cycles 300 
ARFI push length [µs] 55 
ARFI lateral push locations 42 (54°) 
Parallel tracking 1:1 
Pre-tracks 8 
Post tracks 9 
Tracking PRF [kHz] 9.7 
 
 
Hsu et al. determined the peak intracardiac ARFI-induced displacement in 
myocardium occurred ~0.60 ms post-excitation, thus the excitation location was tracked 
for 0.6 ms (9 scan-lines) to capture the peak tissue response while minimizing the 
acquisition time.96 The total tracking time at each ARFI-excitation location was ~1.1 ms.  
Hsu et al. determined unablated and ablated myocardium fully recover to the pre-
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excitation baseline after ~2.2 ms. The spatial-interleaving of the sequential excitation 
locations during the acquisition ensured the local tissue was unaffected by the previous 
ARFI-excitation.95  The full imaging sequence took ~92 ms to complete and was within 
regulatory limits for mechanical index (MI < 1.7) and transducer surface heating (< 
4.0°C).150   
The ARFI image processing was completed offline after the experimental 
procedure. The 2-D ARFI images were formed using the normalized cross-correlation 
time-delay displacement estimation method outlined by Hsu et al.96  A normalized CCC 
was calculated for each pixel location to quantify the quality of the phase-matching 
between the post ARFI scan-lines and the last pre-ARFI line (reference line).  A low CCC 
for a displacement value indicated phase decorrelation during the cross-correlation, and 
therefore a poor displacement estimation. Poor displacement estimates were removed 
from the ARFI images by thresholding the median CCC (median CCC through tracking 
time was spatially median filtered by a ~0.5 mm axial by 4 mm lateral kernel) to include 
only values greater than 0.80. This processes eliminated most of the pixels from the 
blood in the RA. 
The ARFI-induced displacement measurements were motion filtered with a 
quadratic extrapolation model to reduce the effects of axial physiological motion and 
catheter rebound on the displacement estimates.96, 136, 151  An example of a displacement 
profile for a single pixel in unablated myocardium is presented in figure 14.   
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Figure 14: ARFI-induced displacement curve for a single pixel location in the 
myocardium imaged with an ICE transducer.  In the ICE imaging sequences, 10 
priming pulses were delivered to linearize the transducer kick-back.  As a result, the 
catheter is recovering towards the myocardium during the eight pre-excitation scan-
lines. This motion was removed from the raw displacements (triangles) using the 
quadratic motion function (blue) extrapolated from the pre-track data to create a 
profile of only the ARFI-induced displacement (circles). Nine scan-lines were 
collected to monitor the post-excitation tissue displacement.  Total tracking time for a 
single line was ~1 ms.  The maximum displacement over the tracking time (magenta 
star) was the pixel value in the 2-D ARFI image. 
 
Remaining pixels in the blood or beyond the myocardium were masked from the 
image by removing individual locations if the measured displacement estimation was > 
50 µm (likely noise) or the standard deviation of the displacement measurements 
through the tracking time was greater than 20 µm.  The maximum ARFI-induced 
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displacement measurements were scan-converted (bilinear interpolation scan-
conversion, 0.019 mm axial by ~1.33° lateral kernel pre scan-conversion, 0.05x0.05 mm 
pixel size post scan-conversion), color-coded at each pixel location, and overlaid onto 
the scan-converted B-mode image.  The ARFI image pixel color scale was manually 
adjusted to increase the visual contrast and reduce saturation in the final displayed 
image. The upper limit of the displayed displacement range for all images was between 
7.5 and 15 μm. 
4.2.1.2 Hardware and Software Integration 
The developed multi-modality imaging system consisted of a modified CARTO 
XP™ EP Navigation System (Biosense Webster; Diamond Bar, CA) and the software 
modified Siemens ACUSON S2000™ ultrasound scanner (Siemens Healthcare; Issaquah, 
WA). The S2000 platform used for this research was not supported by the CARTO XP 
software, and custom hardware and software modifications were made to the CARTO 
XP to complete the integration. 
In the standard clinical system, the CARTO XP EAM system connects to a 
supported ultrasound scanner with an Ethernet cord and proprietary video cable.  The 
CARTO XP software retrieves the ultrasound imaging parameters, such as the imaging 
fan depth, through the Ethernet connection and crops the real-time ICE video from the 
scanner to display in the electroanatomical map.  To receive the correct video input from 
the S2000 scanner, a compatible frame grabber card (Vio Analog, VIO7IAOA/G*: Matrox 
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Electronic Systems Ltd., Dorval, Quebec, Canada) was installed in the CARTO computer 
tower to accommodate the video resolution output by the S2000.  A custom Matrox 
Intellicam software (Matrox Electronic Systems Ltd., Dorval, Quebec, Canada) 
parameters file was developed with the assistance of Matrox to accept the exact video 
specifications of the S2000 output.  A CARTO XP software update (V9.7) and a 
parameter “simulating” software (modified from the supported ACUSON X300™, 
Siemens Healthcare; Issaquah, WA;) provided by the Biosense Webster CARTO 
Software Development team (Tirat Carmel, Israel) was installed on the CARTO XP 
system to correctly crop and display the S2000 video signal in the CARTOSound™ 
Ultrasound Viewer window.  The simulator provided modifiable, hard coded XML files 
to provide the imaging parameters from the S2000 scanner to the CARTO XP software.  
The S2000 parameter values were found in the scanner Diagnostic User Interface (DUI) 
and with a screenshot of the S2000 imaging software.  Once the video input and XML 
file modification was complete, the real-time ICE imaging fan was visible in the CARTO 
XP ultrasound viewer. 
4.2.1.3 Imaging System Implementation and Equipment Setup  
The ARFI imaging-EAM integrated system used a commercially available 
unmodified 10 French SoundStar™ catheter (Biosense Webster; Diamond Bar, CA) to 
acquire spatially registered B-mode and ARFI images.  Preliminarily processed ARFI 
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images were displayed on a laptop computer (Dell Precision M90) within 15 seconds of 
the acquisition during the procedure. 
Catheters were navigated to the heart with fluoroscopy (Philips Healthcare; 
Andover, MA).  All focal RFA lesions were delivered with a Stockert 70 radiofrequency 
generator (RFG) and NaviStar mapping/ablation catheter (Biosense Webster; Diamond 
Bar, CA). An octapolar reference catheter (XT™ Steerable, Bard; Lowell, MA) was 
positioned in the CS and the distal electrodes were used as pacing electrodes (Pulse 
Stimulator, Grass Technologies; West Warwick, RI). 
The surface ECG and endocardial EG from the electrodes of the reference (R1-R8) 
and mapping (M1-M4) catheters were acquired by the CARTO patient interface unit 
(PIU), input into an Octal Bio Amp (ADInstruments; Milford, MA) using a custom 
fabricated cable (figure 15), and recorded using LabChart 7.0 data acquisition software 
(PowerLab, ADInstruments).  In LabChart, an output channel was configured to provide 
an impulse at a user selected delay after a detected QRS of the ECG. This pseudo-ECG 
output signal was fed to the ultrasound scanner using a custom fabricated cable (figure 
16) and used to gate the image acquisitions.  The output signal was also input into the 
CARTO PIU (custom fabricated cable, figure 17) as a pseudo-EG signal to synchronize 
the CARTO XP position recoding and display (position data acquired once per heart 
beat) with the gated ARFI image acquisition.   
A diagram of the full equipment setup is presented in figure 18. 
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Figure 15: Custom cable for transferring intracardiac (IC) EG recorded by the 
reference catheter (R1-R8) and mapping catheter (M1-M4) from the CARTO system to 
the bioamp data acquisition system. 
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Figure 16: Custom cable to for input of pseudo-ECG from data acquisition 
system to the S2000 ultrasound scanner. 
 
Figure 17: Custom cable to for input of pseudo-EG synchronization signal 
from data acquisition system to the CARTO. 
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Figure 18: Diagram of ARFI imaging-EAM equipment and cable connections. 
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4.2.2 Integrated System Verification 
 The integrated system was tested in two canine subjects to confirm the spatial 
registration of the imaging plane and CARTO geometry.  In the first canine subject, the 
integrated CARTO system was used to steer the ARFI imaging plane to interrogate two 
single RFA lesions before and after ablation.  In a second canine, two parallel rows of 
RFA lesions were delivered in the RA, and the integrated system was used to visualize 
and ablate the unablated gap between the RFA lines. 
4.2.3 ARFI Imaging of Linear RFA 
A linear ablation was performed in eight canine subjects.  A baseline point-by-
point geometry of the RA was made with the ARFI imaging-EAM system. A guideline 
delineating the planned linear RFA delivery site was drawn on the map geometry, and 
EAM directed ARFI images of the pre-ablated tissue regions were acquired.  A series of 
lesions were delivered along the guideline using a catheter dragging technique to 
minimize potential lesion line discontinuities, and the RFA sites were marked in the 
EAM geometry.152  The ablation proceeded in two steps: first, the linear ablation left an 
intentional gap of approximately 1 cm length, and then the gap was closed with 
consolidating RFA lesions. The ablation catheter tip was temperature controlled between 
50-60˚C and RF-energy was applied for ~30-90 seconds per line segment. ARFI images 
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were acquired before and after RFA using the EAM geometry and guideline markers to 
direct the imaging.  
The ablation catheter was removed from the FOV during ARFI imaging because 
the catheter tip blocked acoustic energy from reaching the myocardium, creating a 
distinct shadowing artifact. Also, the ICE catheter was positioned such that the 
endocardium appeared near the focus and as parallel to the transducer face as possible.  
This was done to maximize the induced displacement and to minimize depth dependent 
energy delivery to the tissue.25, 96, 139  ARFI images where the endocardial surface was 
outside the focal DOF (above 0.5 or below 2.25 cm) were not included in the statistical 
analysis. Images were also excluded if the myocardium was at an angle greater than 50˚ 
because the depth dependent difference in acoustic energy-delivery could potentially be 
mistaken for RFA treatment.139 
After the procedure, the heart was removed and photographed to confirm the 
presence of RFA lesions at the approximate sites shown in the electroanatomical map. 
4.2.3.1 ARFI Image Review for the Presence of RFA Lesion 
Three reviewers read the processed ARFI images for the absence or presence of 
RFA lesion in the myocardium at the imaging location, identifying lesion as at least one 
area (larger than approximately 0.5x0.5 mm) of low relative ARFI-induced displacement. 
The ARFI images were randomized, and each reviewer was blinded to the CARTO 
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maps, canine subject, and stage of ablation.  The majority assessment was used as the 
final classification of the image, and the level of agreement between the reviewers was 
quantified with a kappa coefficient.  In the CARTO maps, the ARFI imaging plane 
transecting any part of a 4 mm spherical RFA marker was used to indicate the presence 
of a RFA lesion at the imaging location. Each image was categorized in a 2x2 
contingency table, and the sensitivity and specificity were calculated. 
4.2.3.2 Contrast Performance Analysis of ARFI-induced Displacements in Unablated 
vs. Ablated Myocardium 
A reviewer was blinded to the ARFI images and used the CARTO maps of the 
RFA markers and ICE-fan projection to classify each location as imaging no lesion (fan 
did not intersect markers), non-contiguous lesion (fan partially intersected marker lines), 
or contiguous lesion (fan completely intersected marker lines).  Images that partially 
intersected RFA marker lines were used for the contrast analysis.  For these images, the 
reviewer manually selected an ablated and unablated area in the myocardium on the B-
mode image that matched to the marker intersection of the fan in the EAM map.  This 
selection dictated the location of two (one ablated, one unablated) 1x1 mm (20x20 pixels) 
regions of interest (ROI) in the spatially registered ARFI image.  For the ARFI images of 
no lesion and contiguous lesion, a 2x1 mm (40x20 pixels) region of interest was taken 
from the center of the FOV.  Each image contributed the same number of data points 
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(800 total pixels) to the analysis.  The 1 mm axial depth for the ROI was chosen because 
the atrial myocardium was typically between 1.5 and 2 mm thick.  All ROI were taken 
0.25 mm below a manual trace of the endocardial surface on the B-mode to ensure the 
measurement region was within the myocardium. 
The mean and standard deviation of the ARFI-induced displacement (no spatial 
median filter) were calculated for the pixels in each ROI.  A repeated measures ANOVA 
to test for the RFA lesion effect was performed on the ROI displacement values.  This 
statistical model was used because multiple lesions were created in each animal. 
The C and CNR were calculated for each image containing both ablated and 
unablated myocardium.  The C and CNR were also calculated for the mean signal 
amplitude in the spatially registered ROI in the B-mode images.  A repeated measured 
ANOVA for lesion was performed on the measured ROI displacement means.  
Additional repeated measure ANOVA tests were performed on the C and CNR values 
in the ARFI and B-mode images.  A one-tailed paired t-test was used to determine if 
there was a significant increase in the C and CNR of lesion in the ARFI images over the 
B-mode images. 
4.2.3.3 Bulk Motion Artifacts 
The motion filtering technique described previously reduced the effects of bulk 
axial motion on the ARFI-induced displacement estimates, but large motion artifacts 
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(severe decorrelation of the track-lines) occurred if an acquisition was mistimed to 
acquire partially in systole or during an irregular heartbeat such as a premature 
ventricular contraction (PVC).  The ARFI image scan-lines were acquired at spatially-
interleaved lateral locations; therefore if substantial lateral or axial motion occurred 
during the acquisition, the endocardial surface was discontinuous or “jagged” in the B-
mode image compiled from the pre-ARFI excitation RF track-lines (figure 19).  Motion 
artifacts also presented a distinct “streaking” pattern in the displacement estimates that 
corresponded to the tracking of the largely decorrelated bulk cardiac motion instead of 
the ARFI-induced displacements.   
ARFI images exhibiting such motion artifacts or images where more than 50% of 
the displacement estimates in the myocardium had cross-correlation coefficients below 
0.80 were not included in the statistical analysis (28 of 247 total images). 
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Figure 19: Motion artifact in B-mode image (RF data).  The ARFI lines were 
acquired at the spatially interleaved locations dictated by the order of the blue 
numbers.  A total of 42 lines were acquired across the FOV (before scan conversion).  
There is a discontinuity at the myocardial surface in the center of the field of view 
(white line) that shows the tissue had moved between the acquisition of the center 
line acquired at the beginning of the sequence and the line to the left that was 
acquired at the end of the sequence. 
 
4.3 Results 
4.3.1 Integrated System Verification 
Figure 20 shows ARFI images of a right atrial RFA target site mapped in the 
CARTO geometry before (white sphere) and after (red sphere) ablation.  Post ablation, 
there is a clear area of increased stiffness in the location of the CARTO RFA marker.  
Figure 21 is a second example of ARFI imaging of a single RFA lesion site in the RV.  
There is a region of increased stiffness at this location where the imaging plane intersects 
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the RFA marker.  In figure 22, ARFI imaging verified an unablated gap between two 
parallel lines of RFA lesions after ablation.  When consolidating RFA was delivered, the 
gap of relatively low ARFI-induced displacements became stiffer.  These results verified 
the ARFI imaging plane was accurately imaging RFA delivery locations using the 
CARTO map as a guide.  
 
 
 
Figure 20: CARTO maps (left) and ARFI images (center) of a single RFA lesion 
in the right atrium (RA) before and after radiofrequency ablation (RFA).  Post 
ablation the ARFI image shows a decrease in the relative ARFI-induced displacement 
(µm) where the imaging plane transects the RFA lesion site (red sphere) in the 
CARTO map.  An image of the tissue pathology (right) confirmed the presence of a 
transmural lesion. 
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Figure 21: CARTO maps (right column) and ARFI images (center column) of 
single RFA lesion in the right ventricle (RV) before and after ablation.  Post ablation 
the ARFI image shows a decrease in the relative ARFI-induced displacement (µm) 
where the imaging plane transects the RFA lesions site (red sphere) in the CARTO 
map.  An image of the RV epicardial surface (right column) confirms the RFA lesion 
was not transmural. 
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Figure 22: CARTO maps (right column) and ARFI images (center column) of a 
unablated gap between lesions before and after ablation.  Before RFA (top row) the 
myocardium exhibits homogeneous ARFI-induced displacements (µm).  After the 
delivery of two parallel RFA lines (middle row), ARFI imaging displayed a relatively 
soft region of unablated myocardium at the gap between the RFA lesions markers 
(red spheres) in the CARTO map.  The relative stiffness increases when additional 
RFA is delivered at this gap.  An image of the endocardial tissue pathology (right 
column) confirms a solid ablation line and the approximate imaging plane (IP) 
location. 
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4.3.2 Identification of RFA Sites with ARFI Imaging 
A total of 219 ARFI images were read for the presence of lesions. Figure 23 is an 
example of ARFI images acquired before and after incomplete and complete linear RFA.  
Before RFA, the myocardium in the ARFI images exhibited relatively high ARFI-
induced displacement, color coded by the red-orange spectrum of the color bar. Post 
ablation, the measured ARFI-induced displacements were lower in the RFA lesion 
(colored blue-green), indicating an increase in the tissue stiffness and the presence of 
lesions.  The ARFI image of incomplete linear ablation confirmed an unablated gap in 
the lesion line.  Table 7 shows the categorization of the 219 ARFI images.  Reviewers of 
the ARFI images showed substantial agreement (kappa = 0.73) and the majority review 
identified RFA lesion sites with a sensitivity of 90.2% and a specificity of 94.3%.  The 
RFA lesion width observed in the postmortem pathology photographs was typically 
between 4 and 8 mm. 
 
Table 7: ARFI imaging based confirmation of RFA lesion sites in EAM (4-mm RFA 
marker diameter). 
 ARFI Image Lesion Assessment 
No RFA 
Detected 
RFA Detected Total 
RFA Marker 
Location in 
EAM 
No RFA Lesion 55 9 64 
RFA Lesion 6 149 155 
Total 61 158 219 
   Sensitivity = 90.2%; Specificity = 94.3%; chi-squared test p<0.0001 
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Figure 23: ARFI images before RFA (row A), after the delivery of a non-
contiguous ablation line (row B), and after a complete linear ablation (row C) in a 
canine right atrium. The ARFI imaging plane was steered to transect the RFA lesion 
sites geometry (red spheres, 4-mm diameter) that are marked in the EAM (column 1). 
Conventional B-mode images look similar pre and post ablation. The ARFI images 
(column 3) exhibit low ARFI-induced displacement at the RFA ablation sites. The 
regions of interest for unablated and ablated myocardium are outlined in white. Color 
scale units are micrometers axial displacement away from the transducer.    
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4.3.3 Contrast of the ARFI-induced Displacements in RFA Lesion 
Figure 24 plots the mean and standard deviation of the all the ARFI-induced 
displacement measurements in unablated and ablated canine myocardium. Table 8 
summarizes the results of the statistical analysis.  The mean displacement (all images, n 
= 219) was lower in ablated than unablated ROI (n = 143 unablated, n = 152 ablated).  A 
repeated measures ANOVA indicated the presence of RFA lesion had a significant effect 
(p = 0.0001) on the measured displacements, whereas the canine subject did not (p = 
0.11).   
For images that contained both RFA lesion and unablated myocardium (n = 76 
paired ROI images), the mean measured ARFI-induced displacement was lower for the 
ablated ROI.  A repeated measures ANOVA determined that the presence of RFA lesion 
had a significant (p = 0.0004) effect on the measured displacement means and the canine 
subject did not at an alpha value of 0.01 (p = 0.03). 
Table 8 presents the average C and CNR for the ARFI and B-mode images 
containing both unablated and ablated ROI.  The B-mode image C and CNR were 
significantly lower than the ARFI image C and CNR based on a one-tailed paired t-test 
(p < 0.001).  A repeated measures ANOVA determined the canine subject did not 
significantly affect the C and CNR for the ARFI (pC = 0.36, pCNR = 0.72) and B-mode (pC = 
0.52, pCNR = 0.73) images.   
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Figure 24: Boxplot of maximum ARFI-induced displacements for ROI in 
unablated and ablated canine myocardium (n = 219 images). The center line 
represents the median ARFI-induced displacement measurement. The top and bottom 
edges of the box (shown in blue) are the 75th and 25th percent quartiles. The top and 
bottom whisker edges are the extreme values (covering 99.3% of the data), and the 
individually plotted crosses (shown in red) are statistical outliers. 
 
The criteria described in the methods (low CCC, unrealistic estimates) removed 
ARFI-induced displacement pixels from 33 ROI.  Of these ROI, six had more than 5% of 
the pixels removed and no ROI had more than 17% of the pixels removed.  No pixels 
were removed from the B-mode image ROI. 
 77 
 
Table 8: Mean and standard deviations of the ARFI image ROI displacements and 
contrast analysis for ROI in unablated and ablated myocardium. 
 Paired‡ Images All* Images 
B-mode ARFI§ ARFI† 
Unablated Myocardium (µm) - 8.31±4.30 11.23±1.71 
Ablated Myocardium (µm) - 5.11±2.36 6.06±0.94 
Contrast (C) ∥ -0.03±0.28 0.29±0.33 - 
Contrast-to-noise ratio (CNR) ∥ 0.74±0.68 1.83±1.75 - 
* 219 total images in 8 canine subjects 
† n = 143 unablated ROI, 152 ablated ROI; repeated measures ANOVA, subject effect (p = 0.11, F = 2.61) and 
lesion effect (p = 0.0001, F = 47.21) 
‡ 76 paired images in 8 canine subjects 
§ n = 76 unablated ROI, 76 ablated ROI; repeated measures ANOVA, subject effect (p = 0.03, F = 4.67) and 
lesion effect (p = 0.0004, F = 31.54)  
∥ repeated measures ANOVA analysis of subject effect of ARFI image C (p = 0.36, F 1.12), and CNR (p = 0.72, 
F = 0.64) and B-mode C (p = 0.52, F = 0.89) and CNR (p = 0.73, F = 0.63); one-tailed paired t-test for C (p = 
1.15e-8) and CNR (p = 7.54e-7) between ARFI and B-mode images 
 
4.4 Discussion and Conclusions 
This chapter described the verification and use of an integrated ARFI imaging-
EAM system for precise intraprocedure ARFI imaging of RFA treatment sites.  A 
quantitative analysis showed RFA locations exhibited significantly lower maximum 
ARFI-induced displacements than untreated areas, and reviewers of the ARFI images 
identified RFA lesion sites with high sensitivity and specificity.  The C and CNR 
indicated there was excellent contrast between the RFA lesion and unablated 
myocardium in the ARFI images, and the C and CNR were significantly higher in ARFI 
imaging than in conventional ICE images. 
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4.4.1 Qualitative Imaging 
In this chapter, the quantitative analysis showed that ablated regions exhibit 
lower measured ARFI-induced displacements; however it is important to note that the 
measured ARFI-induced displacements are qualitative surrogates for relative tissue 
stiffness, and do not directly quantify a material property.  Imaging the same location 
from a different angle, depth, or with different imaging parameters, such as frequency, 
focal depth, or F/# could result in different measurement ranges of ARFI-induced 
displacement.  This study determined the range of the measurements and contrast for 
specific but clinically feasibly imaging conditions: the myocardium was imaged 1) in 
diastole, 2) within a specific focal depth range (0.5 to 2.25 cm below the transducer), 3) 
from a non-oblique angle (<50°), and 4) off-axis steering of the ultrasound beams was 
limited to ±27°.  It is also important to note that negative displacement amplitudes and 
amplitudes above 50 µm were removed from the ROI before calculating the mean 
displacement; these bounds contributed to the skewed distributions and non-normal 
appearance of the plots in figure 24. 
Despite the lack of a quantitative measure, qualitative ARFI imaging is optimally 
suited to image discrete targets of differing stiffness, such as ablation lesions. ARFI 
images have a spatial resolution that is dependent on the spatial density of the 
measurements.  At 1.5 cm distance from the transducer, the imaging lines are 0.33 mm 
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apart.  We believe this spatial sampling is adequate to visualize gaps greater than 0.66 
mm.  However, the measured gap resolution is unknown at this time and its value will 
be a critical factor in determining overall clinical effectiveness. Shear wave elasticity 
imaging (SWEI) has also been shown to be useful for quantifying the elasticity changes 
associated with RFA treatment.153, 154  However, shear wave speed calculation requires a 
spatial kernel that can result in lower resolution; it is not yet clear if the resolution of 
SWEI images is adequate for the assessment of lesion line gaps. 
The contrast analysis presented in this chapter demonstrated that the relative 
contrast in a single ARFI image can differentiate RFA lesion from non-lesion. This ability 
could provide a useful tool for TCA procedure guidance, where exact quantification of 
the tissue properties is not necessary.  
Due to the qualitative nature of the image, the development of a method to 
automatically detect RFA lesion based on the value of the measured ARFI-induced 
displacements would require further investigation.  In the previous chapter, a pre-
ablation image was used to normalize the relative displacements.  While this exact 
technique is not translatable to single intraprocedure images acquired during TCA, the 
development of a spatial normalization algorithm to compensate for the acoustic energy 
attenuation through depth and at extreme steering angles could increase the likelihood 
of developing an effective automatic segmentation method. 
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4.4.2 Considerations for Clinical Translation 
As previously mentioned, diastolic imaging is necessary for successful ARFI 
imaging of lesions as most of the contrast between lesion and normal tissue disappears 
when the tissue stiffens during systole.95, 96, 133, 155  Also, late diastole is the time of least 
intrinsic motion during the cardiac cycle.  We manually set the post QRS delay to start 
the imaging in late diastole; however, this delay had to be adjusted multiple times 
throughout the study to account for changes in heart rate.  Two of the false-positive 
images (ARFI image reader detected lesion, no marker in EAM) were acquired before 
the RFA delivery phase of the experiment, and may have indicated low ARFI-induced 
displacement due to a poor gating delay. Mistiming the acquisition due to intermittent 
variations in heart rate may have also contributed to the high number of images with 
motion artifacts.  The development of a software tool to adjust the gating delay in real-
time could potentially reduce the instances of motion artifacts. Shortening the 
acquisition time of the imaging sequence could also help reduce the physiological 
motion during the acquisition. 
Imaging the myocardium with the transducer face parallel to the endocardium 
and at the center of the focal DOF provided the highest contrast ARFI images. Using 
these criteria, we were able to acquire a substantial number of high-quality ARFI images 
in the canine RA.  The restricted DOF made imaging some areas of the canine heart 
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challenging, and may limit the number of sites that can be imaged with contemporary 
ICE catheters during a clinical TCA procedures. Significant technical advances to 
address these limitations, such as the development of an ARFI imaging optimized 
transducer or more flexible ICE catheter steering technology, would improve the 
likelihood of clinical translation. 
ARFI images require multiple ultrasound scan-lines at each ARFI-excitation 
location to monitor the tissue deformation and therefore cannot be acquired at the same 
high frame rate as B-mode.  This, combined with need for diastolic imaging means that 
continuous display ARFI imaging for lesion evaluation is not possible. Accelerated ARFI 
imaging could allow the acquisition of multiple frames in a single beat, but any increase 
in the ARFI imaging acquisition rates must consider the effects of increased acoustic 
exposure (mechanical index/transducer face heating).  With this in mind, the 
development of 3-D ARFI imaging could reduce the number of acquisitions needed to 
interrogate a lesion line.  
Due to the restricted DOF, ARFI imaging lesion evaluation in the left atrium (LA) 
would require a double transseptal puncture to position the ICE catheter across the 
atrial septum.  While ICE imaging in the LA is not mandatory for TCA procedures, it is a 
safe and effective method used by many electrophysiologists to monitor RF-delivery and 
the ablation catheter contact in real-time.  In this study, ARFI images were acquired in 
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the canine RA to avoid performing a double transseptal puncture; transseptal punctures 
are difficult in the smaller canine heart.  While these results were obtained in the RA, it 
is expected that similar results would be found in the LA. 
4.4.3 Considerations for EAM Guided ARFI Imaging 
The experiment described in this chapter determined EAM was an indispensable 
tool for mapping RFA treatment sites and guiding the imaging plane.  The RFA markers 
in EAM were treated as the gold-standard for indicating lesion locations.  The 
experiment was designed this way because attempting to match the exact orientation 
and location of each imaging plane to the ex vivo pathology would risk substantial 
misregistration errors that would affect the accuracy of the lesion evaluations.  A 
concern when using EAM as the gold-standard was that the RFA markers themselves 
only indirectly inferred RFA delivery; the EAM marker did not directly indicate the 
presence or size of an actual lesion.  Discrepancies between the actual pathological lesion 
configuration and the electroanatomical map could have resulted in the incorrect 
classification (ablated vs. unablated) of some ROI in the ARFI images.  These 
misclassifications likely affected the statistical analysis and the C and CNR calculations.  
For example, the six false-negative sites in table 7 could have been sites where the RF-
energy did not induce a high enough temperature for ablation despite the location 
marker or the lesion could have been very small (<4 mm) due to poor electrode-
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endocardium contact.  At six of the nine false-positive sites, the imaging plane was 
positioned within ~4 mm of a lesion marker.  One of the eight was within ~8 mm.  In 
these cases, the pre-determined marker diameter of 4 mm in the EAM could have 
contributed to the misclassifications.  In the pathology examination, several lesions were 
substantially larger (> 8 mm) than the EAM marker diameter.  Despite this potential for 
misclassification, expert reviews of the ARFI images were very highly correlated with 
the presence of the RFA markers in the EAM. 
4.4.4 Study Limitations 
It is important to note that the displacement ranges, C, and CNR were calculated 
from the maximum ARFI-induced displacement measurements within 0.6 ms of the 
ARFI-excitation.  An examination of these parameters at different time points after the 
ARFI-excitation could potentially result in different values for measured 
displacement.114, 156-158  Also, the ~0.60 ms post tracking time may not have captured the 
peak displacement in some locations.  An optimization of ICE-based ARFI sequences 
would have to balance any increase in tracking time with overall lengthening of the 
sequence.  Lengthening the sequence increases the effects of bulk tissue motion during 
the acquisition and would change the safety parameters affected by increased acoustic 
exposure.  
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ARFI imaging of lesion borders can result in shear wave (off-axis mechanical 
wave propagation) reflections from lesion-tissue boundaries.25, 158, 159  The potential effect 
of such interactions on the contrast for thin (1–3 mm) inhomogeneous viscoelastic atrial 
tissue with irregular ablation lesion borders are beyond the scope of this thesis. 
In this study, the maximum ARFI-induced displacement was not compared for 
the same exact sites before and after ablation. Therefore, stiffness inhomogeneity in the 
atrial tissue could be mistaken for RFA lesion in the ARFI images.  Despite this 
possibility, in the healthy canine heart it is expected that such inhomogeneities would be 
minimal. 
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Chapter 5:  Correlation of Electrical Substrate 
Modification and RFA-Induced Stiffness Changes 
in ARFI Imaging 
 
The work described in this chapter was published in the following manuscript: 
 
Eyerly SA, Bahnson TD, Koontz JI, Bradway DP, Dumont DM, Trahey GE, Wolf PD.  
Intracardiac Acoustic Radiation Force Impulse Imaging: A Novel Imaging Method for 
Intraprocedural Evaluation of Radiofrequency Ablation Lesions. Heart Rhythm. 2012.  Vol. 9, 
11:1855-1862. 
 
5.1 Introduction 
The aim of the previous chapter was to verify the use of an integrated ARFI and 
EAM imaging system for intraprocedure imaging of RFA lesions using ARFI imaging.  
Reviewer successfully identified RFA lesion locations in EAM based on the relative 
stiffness contrast between the lesion and unablated myocardium.  While evaluation of 
the location and extent of the tissue damage is important, to be a clinically relevant 
method for lesion evaluation during TCA the presence of lesions in the ARFI images 
must also correlate with the electrical substrate modification, particularly electrical block 
at the ablation site. 
The ARFI images from the animal experiment described in the last chapter were 
used to determine if ARFI-based lesion assessments accurately identified areas of 
 86 
 
conduction disturbance and electrical block.  It is hypothesized that ARFI image 
locations that contain no RFA lesion or non-contiguous lesion will show electrical 
conduction in the EAM local activation time (LAT) map, while locations showing 
transmural, contiguous lesion will exhibit conduction block in the LAT map. 
The chapter is organized as follows:  Section 5.2 describes the in vivo ARFI 
imaging and conduction mapping protocol as well as the evaluation methods used for 
the LAT maps and ARFI images.   Section 5.3 describes the correlation of the ARFI 
imaging and LAT map evaluations, and section 5.4 discusses considerations and the 
potential importance of the results for clinical translation. 
5.2 Methods 
5.2.1 ARFI Imaging Protocol and Experimental Setup 
The full equipment setup (including the ARFI imaging-EAM integration) and 
ARFI imaging procedure used for this study were described in chapter 4.   The ARFI 
imaging sequences were also identical to those presented in the previous chapter.  Refer 
to chapter 4 for specific details regarding the ARFI imaging protocol. 
5.2.2 Animal Experimental Protocol 
The animal experimental protocol described in this chapter was conducted on 
the same animal subjects as described in chapter 4. 
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In each canine subject, a baseline point-by-point geometry and LAT map was 
made of the RA with the Navistar mapping catheter and CARTO XP navigation system 
(Biosense Webster; Diamond Bar, CA).  A pre-RFA guideline of points delineating the 
intended ablation sites was drawn on the CARTO LAT map; baseline ARFI images were 
acquired along this guideline. The ICE fan position and orientation for each ARFI 
imaging location was saved for post-procedure review. Discrete RFA lesions were 
delivered along the guideline in two stages. The first stage left an intentional ~1 cm gap, 
and the gap was closed in the second stage.  
After each stage, a new LAT map was constructed and the ablation line was 
ARFI imaged.  See figure 34 in appendix A for examples of LAT maps and RFA site 
markers for a canine RA before RFA, after the incomplete linear RFA, and after complete 
linear ablation with confirmed full conduction block.   
At the end of the study, the animal was euthanized and the heart was removed 
to confirm lesion delivery. The RFA lesions were photographed with a digital camera. 
5.2.3 Local Activation Time Map Evaluation 
Screenshots of each imaging fan position were compiled with the LAT map using 
the CARTOSound Module in the system Review Mode. The tricuspid annulus (TA) was 
cut from the map, and internal points were removed. The ablation (red spheres) and 
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guideline markers were hidden, and the color scale of each LAT map was adjusted to 
increase the color gradient at the ablation line.   
The LAT maps for each ARFI image location were randomized and read by three 
different reviewers who were blinded to the ARFI images, the stage of ablation, and 
canine subject. 
The reviewers (two clinical electrophysiologists, one electrophysiology expert) 
were posed three yes or no questions about each LAT map in reference to the baseline 
map: 1) “Is there conduction block anywhere on this LAT map?” (additional possible answer 
of “Cannot be determined”), 2) “Based on the activation pattern in the LAT map, does there 
appear to be RF lesions present at the ICE imaging fan location?”, and 3) “Is the ICE imaging 
plane completely parallel to and transecting a line of block, thereby imaging a continuous line of 
lesion?”. The RFA lesion widths observed in the postmortem pathology photographs 
were typically between 4 and 8 mm; therefore, questions #2 and #3 were answered 
considering the imaging plane could be transecting RFA lesions within ~8 mm of 
conduction block.  The majority (at least 2 of 3 reviewers) responses to the questions 
determined the final evaluations. 
5.2.4 ARFI Image Evaluation 
The ARFI images were randomized and read by three different reviewers who 
were blinded to the CARTO maps, stage of ablation, and canine subject. 
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The reviewers (all experienced in ARFI imaging) were instructed to classify the 
ARFI images into one of three categories: 1) no lesion, defined as the ARFI image depicts 
no visible area of low relative displacement in the myocardium, 2) non-contiguous lesion, 
depicts at least one area of low relative displacement that does not extend the entire 
length or depth of the imaged myocardium, or 3) contiguous lesion, the full extent of the 
imaged myocardium depicts low relative displacement.  The majority (at least 2 of 3 
reviewers) review determined the final image classification. 
5.2.5 Statistical Analysis of Evaluations 
The degree of the agreement within the sets of three reviewers was quantified 
with the kappa statistic.160  Image pairs where the LAT map evaluation had no majority 
review or the majority review misidentified the correct stage of ablation (question #1, 
pre vs. post RFA) were also removed from the analysis. 
The majority ARFI image categorization and LAT map assessment from question 
#2 were used to compile a 2x2 contingency table of all image pairs to summarize the 
ability of ARFI imaging to identify RFA induced conduction disturbances.  For the ARFI 
images, the category “lesion” included the non-contiguous and continuous 
classifications.  A second 2x2 contingency table was compiled to summarize the ability 
of ARFI imaging to identify conductive lesion line discontinuities and conduction block 
using the LAT map evaluations from questions #2 and #3.  This table only included post-
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ablation image pairs with a yes response to LAT map assessment question #2. The 
sensitivity, specificity, positive predictive value (PPV), and negative predictive value 
(NPV) were calculated for both tables.  Heterogeneity analysis was performed to justify 
pooling the data for all animals. A heterogeneity chi-square statistic was calculated to 
confirm that the data from different animals came from a homogeneous population.20 
5.3 Results 
In eight canine subjects, 243 ARFI images were acquired with the outlined 
imaging conditions (see section 4.2.2).  Twenty-eight images were rejected due to motion 
artifacts; the remaining 219 ARFI image-LAT map pairs (54 pre-ablation, 80 after 
incomplete ablation, and 85 after gap closure) were reviewed for statistical analysis.  
The kappa coefficient for the ARFI image assessments indicated substantial 
agreement (κ = 0.73) between the three reviewers.  The individual kappa coefficients for 
the LAT map review questions showed substantial agreement for identifying lesions at 
the imaging plane (κ = 0.68), and moderate agreement when assessing full conduction 
block at the imaging plane (κ = 0.43).  The LAT map reviewers had different question 
responses (no majority review) for 15 image pairs.  The majority review misidentified 
the correct stage of ablation in five LAT maps. These 20 image pairs we excluded from 
the final analysis.   
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The statistical calculations included 199 image pairs. The reviews for detecting 
RFA treatment with ARFI imaging compared to the reviews for identifying conduction 
disturbance in the LAT map is shown in table 9.  Table 10 shows the ARFI image 
reviews for RFA lesion contiguity vs. functional conduction block (n = 140, includes only 
post ablation image pairs confirmed by the LAT map review).  The heterogeneity 
analysis justified pooling the data from all the animal subjects. Table 11 summarizes the 
heterogeneity chi-square and p-value, sensitivity, specificity, PPV, and NPV for tables 9 
and 10.  
An image pair example from each ablation stage is shown in figure 25.  Before 
RFA (figure 25C-1), the ARFI-induced displacements within the myocardium were 
relatively high and homogeneous.  Figure 25C-2 shows the unablated gap in the lesion 
line, visible as the area of high tissue displacement surrounded by areas of relatively low 
tissue displacement.  The final ARFI image (figure 25C-3) shows a homogeneous region 
of low displacement, confirming complete ablation of the gap. 
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Table 9: ARFI image assessment for RFA treatment. 
ARFI image lesion 
assessment 
LAT map assessment at imaging fan location 
No 
conduction 
disturbance 
Conduction disturbance 
inferring the presence of 
lesions 
Total 
No RFA Lesion 54 6 60 
RFA Lesion 5 134 139 
Total 59 140 199 
 
Table 10: ARFI image assessment for contiguous RFA. 
ARFI image lesion 
assessment 
LAT map assessment at imaging fan location 
 
No block 
 
Block 
 
Total 
Noncontiguous lesion 67 27 94 
Contiguous lesion 22 24 46 
Total 89 51 140 
 
Table 11: Summary of statistical analysis for tables 9 and 10. 
 RFA treatment Contiguous RFA 
n 199 140 
Heterogeneity, χ2 4.59 9.29 
Heterogeneity, p value* 0.7099 0.2325 
Sensitivity (%) 95.7 47.1 
Specificity (%) 91.5 75.3 
PPV (%) 96.4 52.2 
NPV (%) 90.0 71.2 
*Heterogeneity analysis: degrees of freedom = 7, do not reject Ho (8 samples from homogeneous population  
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Figure 25:  An example of three ARFI image-LAT map pairs. Row 1) acquired 
before RFA, row 2) acquired after intentionally creating a 1 cm conductive gap, and 
row 3) acquired after closure of the 1 cm gap. Column A) LAT maps showing the 
imaging fan position in the canine RA and the location of delivered RFA lesions (red 
spherical markers).  Column B) conventional B-mode images acquired at the location 
indicated on the LAT maps.  There is no lesion visible in the B-mode images. Column 
C) Maximum ARFI-induced displacement images.  The color bar units are microns of 
tissue displacement away from the transducer. RFA lesions sites are visible as regions 
of lower relative displacement (stiffer tissue), represented by the blue-green-yellow 
portion of the color bar. 
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5.4 Discussion and Conclusions 
The results of the study described in this chapter confirmed ARFI images 
predicted RFA-induced conduction disturbances at the imaging site on the LAT maps.  
Reviewers of the ARFI images identified RFA treated areas with high sensitivity, 
specificity, and predictive values.  Reviewers also distinguished gaps between adjacent 
RFA lesions that frequently corresponded to conduction “breakthrough” on the 
activation map.  In many cases, ARFI images reviewed as contiguous RFA displayed 
conduction block on the activation map. 
5.4.1 Clinical Translation and Implications 
Lesion evaluation with an ARFI imaging-EAM system could guide the delivery 
of consolidating RFA to conductive lesion line discontinuities, and subsequently 
decrease the total procedure time and increase the success rate of procedures that use 
linear ablation strategies.  An ARFI imaging-EAM system uses existing clinical tools and 
techniques, therefore clinicians would not need to purchase and install expensive new 
equipment in the operating rooms and electrophysiologists would not need significant 
training to use the system. 
5.4.1.1 Distinguishing Conductive from Non-Conductive Unablated Gaps 
Cardio-myocytes near sites of RFA delivery can be reversibly stunned (see 
section 2.2.2), and areas of conduction block observed acutely after circumferential or 
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antral PVI have shown conduction recovery in some patients.21-23  The lower sensitivity 
and discordance between the activation defined completeness of conduction block and 
the ARFI imaging defined lesion contiguity could potentially be explained by the 
indirect functional vs. direct imaging method of assessing block.  Further investigation 
will be required to test if imaging tissue stiffness is a more sensitive measure of ablation 
lesion durability and long-term ablation success than acute activation mapping. 
5.4.2 Study Limitations 
EAM is the current end procedure gold-standard for assessing ablation line 
completeness, therefore this study used EAM to identify regions of conduction 
disturbance or block.  Unfortunately, the accuracy of the LAT maps was largely 
dependent on the mapping catheter stability and EG acquisition density.  For example, 
figure 26C shows an RFA line that was incompletely anchored at the TA.  LAT 
conduction mapping at the annulus was sparse due to the difficulty of achieving stable 
catheter contact at the annulus.  In this case, it was challenging to verify or deny an 
anchored lesion line from the LAT map. The ARFI image (figure 26A) conclusively 
visualizes an unablated region at the TA that likely corresponds to the unanchored gap. 
Adding differential pacing to the methods may have improved the accuracy of these 
ambiguous EAM maps, but this was difficult to achieve in the small canine RA and was 
not performed in this study.  
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Figure 26: Conventional (1) B-mode and (2) ARFI image at the tricuspid 
annulus. The ARFI image shows an area of relatively high displacements at the 
annulus indicating a likely unablated region. ARFI image color bar units are microns 
displacement away from the transducer. B) LAT map surrounding a line of RFA 
lesions in the right atrium, red spheres indicate RFA delivery sites C) Pathology 
photograph of the RA endocardial surface confirming continuous line of RFA lesions 
(LRFA).  A small unablated gap is visible at the tricuspid annulus (TA), indicated by 
the black arrow. 
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Assessing if the 2-D ARFI imaging plane was parallel and completely transecting 
a line of conduction block on the LAT map was challenging; the difficulty was reflected 
in the moderate inter-reviewer agreement.  LAT maps could not provide information 
about lesion line thickness or irregular lesion morphology if the catheter drifted, making 
it difficult to predict the exact extent of RFA treatment based on the functional 
conduction map alone.  Misalignment of the 2-D imaging plane through complete RFA 
lines could be responsible for the low sensitivity (non-contiguous lesion in ARFI image, 
conduction block in LAT) when detecting conduction block.  Such misalignments and 
the corresponding alignment interpretation from the LAT maps were likely a primary 
source of discrepancy between the ARFI imaging and EAM lesion assessments. 
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Chapter 6:  ARFI Imaging of RFA Lesions in Human 
Patients during Clinical TCA 
 
 
6.1 Introduction 
The pre-clinical work described in the previous chapters proved ARFI imaging 
can visualize the relative stiffness difference between untreated myocardium and RFA 
lesion in vivo.  Also, EAM guided intracardiac ARFI imaging successfully identified RF-
delivery locations and conduction disturbances at the imaging site.  Based on these 
findings, a pilot clinical study was undertaken to investigate the feasibility of 
intraprocedure RFA lesion evaluation with ARFI imaging in human patients. 
The following chapter presents images and results from the first human patients 
imaged with intracardiac ARFI imaging.  In six clinical patients undergoing TCA for AF, 
intraprocedure ICE-based ARFI images were acquired at a target ablation site before and 
after RFA to observe any relative stiffness change in the myocardium. 
The chapter is organized as follows: section 6.2 describes the clinical software 
imaging tool developed for the ultrasound scanner and the imaging protocol for the 
clinical patients.  Section 6.3 presents images and observations from the patients, and 
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section 6.4 discusses the technical and procedural successes and challenges encountered 
during this initial clinical experience. 
6.2 Methods 
6.2.1 Clinical Tool for ARFI Imaging 
 A custom software tool was developed at Siemens Healthcare (Issaquah, WA) for 
the S2000™ ultrasound scanner and either a 10 or 8 French AcuNav™ catheter 
transducer (Biosense Webster).  The tool provided an imaging platform within the 
scanner software that allowed the fast acquisition and display of co-registered ICE and 
ARFI images during clinical TCA procedures.  The clinical tool also transitioned quickly 
between live ICE imaging as needed for the clinical procedure and ARFI imaging mode. 
The tool allowed the real-time selection of the ARFI imaging focal depth, 
imaging fan FOV (degrees), and fan imaging direction and depth (within the ICE image) 
using the scanner panel controls.  An ARFI image was acquired with a single button-
press and was displayed overlaid onto the ICE image or in a split screen mode within 
the scanner software.  A screen shot of the ARFI imaging display is shown in figure 27.  
The dynamic range of the ARFI induced displacements could be adjusted in the display 
using the control panel.  A mandatory 3 second “cool-down” time was built into the 
imaging platform to prevent rapid ARFI image acquisitions that could cause excessive 
acoustic exposure or transducer heating. 
 100 
 
 
Figure 27: Screen shots of the clinical ARFI imaging tool software.  The ARFI 
imaging focal depth, field of view, and fan steering angle were user selected using the 
scanner control panel.  The ARFI image was displayed within seconds of the 
acquisition in split screen mode (top) or color overlay mode (bottom). 
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Table 12: ARFI imaging parameters for S2000 clinical studies. 
Transducer Probe AcuNav™ (10 or 8 French) 
 Elements 64 
 Array Type Phased 
 Center Frequency [MHz] 6.15 
Scanner Model (Siemens) S2000™ (ACUSON) 
Data Type IQ 
B-mode 
and ARFI 
Imaging 
Parameters 
Transmit Frequency [MHz] 6.15 
Tracking Frequency [MHz] 6.15 
Sampling Frequency [MHz] 40 
Focus 1.0 – 2.5  cm 
F/# 1.43 – 3.57  
Cycles 300 
ARFI push length [µs] 55 
ARFI lateral push locations 42 (20 – 90°) 
Parallel tracking 2:1 
Pre-tracks 4 
Post tracks 8 – 15 
PRF [kHz] 9.67 
 
 
 
The patient ECG was monitored by an external defibrillator (LifePak 12, 
Medtronic; Minneapolis, MN) during the procedure and relayed to the scanner through 
a custom physio cable (see section 4.2.1.3).  All ARFI images were gated to diastole by 
manually selecting an estimated QRS delay; the delay was determined by observing 
several seconds of m-mode at the imaging location and measuring the time from the 
QRS to diastole (least intrinsic motion). 
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The ranges and fixed parameters for the clinical ARFI imaging tool are presented 
in table 12.  The safety analysis confirmed the sequences were within the FDA limits for 
MI (< 1.7) and transducer surface heating (<4.0°C).150 
6.2.2 ARFI Image Processing 
The raw IQ data was saved for each ARFI image acquisition, and the full image 
processing was completed offline after the procedure.  The measured ARFI-induced 
displacements were calculated from the raw IQ data using a phase-shift estimation 
algorithm (Loups, axial kernel = 1.5λ).124  Poor displacement estimations with low CXCC 
(median through the tracking time was less than 0.90) were removed from the image.117  
Displacement estimations larger than 50 µm were also removed from the image.   
No priming pulses were applied during the acquisition sequence.  The measured 
displacement profiles were motion filtered using a quadratic function interpolated 
between the pre-excitation locations and the four latest post-excitation displacement 
measurements. 130  An example of a single pixel displacement profile from unablated 
myocardium and the resulting motion filter and filtered profile is shown in figure 28.   
After the application of the motion filter, the maximum displacement was found 
for each pixel location.  The data was then median filtered (2.25 mm lateral by 0.462 mm 
axial) and scan converted, and the final image was overlaid onto the B-mode image. 
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Figure 28: ARFI-induced displacement curve for a single pixel location in 
unablated myocardium.  In the clinical ARFI imaging sequences, no priming pulses 
were transmitted.  The raw displacements (triangles) were motion filtered using a 
quadratic motion function (blue) interpolated from the pre-track points and the last 
four post-track points.  This function was subtracted from the raw displacement to 
recover the ARFI-induced displacement profile (circles).  Ten scan-lines were 
collected to monitor the post-excitation tissue displacement.  Total tracking time for a 
single line was ~1.5 ms.  The maximum displacement through time was the pixel 
value in the 2-D ARFI image. 
 
6.2.3 Clinical Imaging Procedure 
Clinical patients undergoing catheter ablation for clinically diagnosed drug-
refractory AF were considered eligible for study enrollment.  All patients provided 
informed consent, and the research protocol was approved by the Duke University 
Institutional Review Board (IRB) for clinical research. 
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Real-time ICE imaging was used to guide a double transseptal puncture for LA 
access.  Two steerable catheter sheaths were positioned through the atrial septum to 
guide the ablation and ICE catheters into the LA.  During the ablation procedure, the 
ultrasound transducer tip was positioned within 2.5 cm of a targeted endocardial RFA 
sites and as parallel to the ICE array as possible (0 – 40°).  These bounds maximized 
acoustic energy to the tissue and minimized any depth dependent energy attenuation.  
A diastolic-gated ARFI image was acquired in NSR before RFA, and three images were 
acquired within several minutes of RF-delivery at the target site.  The ablation catheter 
was removed from the ARFI imaging FOV during image acquisitions; a screenshot was 
taken of the live ICE image during the ablation to verify the ablation catheter contact 
(ACC) site and RF-delivery location.  Images successfully ECG-gated to diastole and 
acquired within transducer positioning bounds were read and analyzed for RFA lesions. 
Standard continuous 2-D ICE imaging was available to the clinical operator at all 
times during the procedure when ARFI images were not being acquired.  ARFI imaging 
added no more than 5–10 minutes to the TCA procedure, and the ARFI images were not 
used to guide ablation during the procedure. 
6.2.4 Statistical Analysis 
The mean ARFI-induced displacement (no spatial median filtering) was 
calculated for a 1x1 mm region of interest (ROI) below the ACC site in the pre-ablation 
 105 
 
image and the three sequential post ablation images.  The ROI locations were manually 
selected using the co-registered B-mode image and ACC snapshot to approximate the 
RFA lesion location; the manual selection of the ROI was blinded to the ARFI image to 
prevent biased selection of the RFA location. 
The mean, standard deviation, and coefficient of variation (standard deviation 
divided by mean) were calculated for the ARFI-induced displacement ROI in the three 
post ablation images.  The percent decrease in displacement at the ablation site was 
calculated by dividing the mean displacement in the pre-ablation ROI by the average of 
the mean (n = 3) displacement for the post ablation ROI. 
6.3 Results 
ARFI images were acquired with the S2000 ARFI imaging tool in six patients 
with drug-refractory AF.  ARFI images were successfully acquired of several anatomical 
structures targeted for ablation, including the LA roofline, posterior wall, and ligament 
of Marshall (LoM).  There were no acute peri-procedural complications in the study 
patients (stroke, pericardial effusion, and pericardial tamponade).  All patients were in 
NSR at the conclusion of the procedure. 
Figure 29 shows the progression of a LA roofline ablation.  As the RFA line is 
created, the ARFI-induced displacements become relatively low (blue) at the ACC site.  
Figure 30 shows three images of RFA treatment at the LA posterior wall.  The RFA 
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lesion is visible as the area of low ARFI-induced displacement, and the displacement 
measurements are repeatable across the three acquisitions.  Figure 31 presents ARFI 
images taken before and after a 60 second RF-delivery on the top of the LoM.  There was 
an observable increase in the myocardial stiffness at the RFA site, but this image 
suggested complete transmural ablation of the LoM was not achieved. 
 
 
Figure 29: ARFI images of sequential RF ablations along the LA roof.  Two-
dimensional ICE images of the ablation catheter contact (ACC, row A) and 
corresponding ARFI images of the transmural RFA lesions (RFA, row B) show there is 
an increase in the myocardium stiffness immediately following 60 second ablation of 
the unablated (UA) myocardium. 
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Figure 30: ARFI images of RFA at the posterior left pulmonary vein antrum. 
The RFA lesion (RFA) displacements in the ARFI images (row B) exhibited relatively 
high stiffness at the ablation catheter contact (ACC) point in the ICE image (row A) 
after a 60 second ablation as compared to the unablated (UA) myocardium.  The AFRI 
images were acquired immediately following RFA (B1) and 12 seconds (B2) and 19 
seconds (B3) after the initial image. 
 
Figure 31: ARFI images of RFA at ligament of Marshall (LoM). There is a 
decrease in the ARFI-induced displacement at the ablation catheter contact (ACC) site 
shown in the live ICE image (B) after a 60 second ablation.  The unablated (UA) 
myocardium to the left and below the lesion suggests transmurality was not achieved. 
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Table 13: Statistical summary of measured ARFI-induced displacements in a 1x1 mm 
region of myocardium below the ACC point before and after RFA. 
Pair 
Imaging 
Location 
(left atrium) 
Pre-RFA Mean 
Displacement 
 (µm) 
Post RFA Mean 
Displacement 
(µm) 
Post RFA 
Coefficient 
of Variation 
Percent 
Decrease 
(%) 
1 Roofline 2.86 2.19±1.00 0.46 23.58±34.85 
2 Roofline 3.22 2.53±0.88 0.35 21.28±27.39 
3 Posterior 5.07 1.95±0.42 0.21 50.68±16.72 
4 LoM 10.36 3.67±0.60 0.16 64.51±5.81 
5 LoM 11.94 2.26±0.23 0.10 81.11±1.94 
6 LoM 4.52 2.73±0.20 0.07 39.58±4.40 
Mean  6.33±3.58 2.56±0.61 0.23±0.15 46.79±23.45 
 
 
In four patients, six RFA locations were ARFI imaged before (single acquisition) 
and after (three sequential acquisitions) a 60 second ablation.  All post images showed a 
decrease in the measured ARFI-induced displacements, and the average percentage 
decrease in the displacements at the ACC site post ablation was ~47%. The average 
coefficient of variation between sequential images (mean of 0.23, range between 0.07 – 
0.46) indicated there was low-variability and good repeatability of the post ablation 
displacement measurements.  A summary of the statistical results is presented in table 
14.  
6.4 Discussion and Conclusions 
The preliminary clinical study presented in this chapter demonstrated ARFI 
imaging is feasible in human patients using catheters and equipment currently available 
for clinical care.  Several anatomical structures typically targeted during TCA for 
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treatment of AF were successfully ARFI imaged from inside the LA.  Intraprocedure 
ARFI imaging identified a ~47% reduction in the relative stiffness in human 
myocardium at RFA sites.  This is similar to the difference between the mean 
displacements seen in the canine subjects between RFA sites and unablated 
myocardium. 
6.4.1 Clinical Experience Observations 
The LoM was imaged in 5 of the 6 clinical patients, and proved to be the easiest 
structure to image in this preliminary patient group.  The LoM is often an 
arrhythmogenic structure, and the complete ablation of the LoM is a primary goal 
during most cardiac ablation procedures for AF.161, 162  It is difficult to achieve transmural 
lesion in the LoM due to the unique shape and thickness; ARFI images of the post RF 
ablated LoM showed incomplete ablation transmurality in 4 of the 5 patients after the 
first round of ablation. 
ARFI imaging could be a useful tool to study the optimal amount of RFA that 
should be applied in specific areas of the atria, such as at the LoM.  Studying the optimal 
RF-delivery duration for structures that need minimal RFA would also be useful.  A 
better understanding of the optimal doses of RFA for the various structures and regions 
of the heart using ARFI imaging could potentially reduce the length of the procedure, 
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the number of redo procedures, and the instance of procedural complications association 
with excessive ablation. 
Two main challenges stood out during the initial clinical studies: 1) the difficulty 
of positioning the catheter parallel to and within 2.5 cm of the myocardium and 2) the 
need for an efficient method to ECG-gate the ARFI acquisitions.   
Quickly and efficiently maneuvering the catheter to within 2.5 cm of the chamber 
wall was very difficult for several locations.  For example, it was only possible to image 
the LA roof when the catheter was in a steerable sheath.  To prepare this technology for 
future trials and widespread clinical adoption, there will likely need to be an increase in 
the usable rage of the system.  It is estimated that a range of 4-6 cm would provide the 
needed utility.  Unfortunately, development of the current ARFI imaging sequences for 
existing clinical ICE transducers would only marginally increase the imaging DOF 
range.  With the current transducer, increasing the focal depth beyond 2.0 cm (F/# > 3) 
decreases the intensity of the focused ARFI-excitation, resulting in a substantial 
reduction in the energy delivered to the tissue and the resultant displacements.  
Therefore, a solution to this obstacle will require the development and optimization of 
the catheter hardware for ARFI imaging.  Possible developments could include more 
controlled steering mechanisms for more degrees of freedom when positioning the ICE 
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catheter, or modifications to the ultrasound transducer to increase the available imaging 
DOF. 
Manual selection of the ECG-gating delay was often inconsistent and time 
consuming.  As in the animal studies, several images contained large motion artifacts 
because the acquisition was not fully completed in diastole.  The development of 
software to automatically detect changes in the heart rate and update the ECG-gating 
delay in real-time could improve the consistency of the acquisition timing.  Displaying 
the ECG and exact acquisition time window would provide an efficient method for the 
operator to quickly discard and reacquire any images that may have been mistimed.  
Future work and further developments for clinical translation, including 
identification of lesion line gaps with ARFI imaging and the correlation with acute and 
long-term electrical block, are discussed in the final chapter of this thesis. 
6.4.2 Study Limitations 
In the pre-clinical studies, the canine subject was in NSR through the majority of 
the cases.  In the clinical patients, the heart was frequently in AF and diastolic-gated 
images could not be acquired.  Several pre-ablation sites were not imaged because the 
heart was in AF, and this resulted in only a few (n = 6) imaging pairs that could be 
analyzed.  A larger number of post ablation images were acquired because the patients 
had been cardioverted and restored to NSR.  While imaging during AF was beyond the 
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scope of this research thesis, an effective method for imaging lesions during AF would 
provide more imaging opportunities in TCA procedures. 
6.5 Acknowledgements 
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Chapter 7:  Conclusions and Future Work 
 
 
7.1 Conclusions 
It has been previously shown in vitro that ARFI imaging accurately measures 
RFA lesions size when compared to tissue pathology.31, 32  A preliminary in vivo study 
demonstrated feasibility of RFA lesion visualization with intracardiac ARFI imaging for 
three endocardial lesions.96 
 The work described in this thesis investigated the hypothesis that ARFI imaging 
can be used for visualization of RFA lesions during cardiac ablation procedures.  This 
hypothesis was successfully proven with four specific aims.  
The transition from an in vitro model to an in vivo model presented new 
challenges that could have affected the ability of ARFI imaging to visualize RFA lesions, 
including: 1) cardiac motion, 2) changes in the myocardium stiffness through the cardiac 
cycle, and 3) transient physiological processes that affect the tissue elasticity such as 
interstitial edema.  In the first aim it was shown that ARFI imaging can be used to 
visualize RFA lesions with high C and CNR during and immediately after RFA in vivo, 
and ARFI determined lesion stiffness and area were temporally and spatially stable 
within several minutes of the ablation.  This experiment demonstrated ARFI imaging 
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can be used to evaluate RFA lesions based on the change in tissue stiffness throughout a 
TCA procedure in a living heart.   
Two-dimensional ARFI image acquisition rates are limited by the time needed to 
acquire the image (50-100 ms) and the necessity for diastolic-gated acquisitions for 
measurable lesion contrast.  With a frame rate of approximately one per second, it 
would be time consuming to scan the cardiac chamber for ablation lesions with 2-D 
ARFI imaging.  An integrated ARFI imaging-EAM system was developed in the second 
research aim to efficiently guide intraprocedure ARFI imaging of RFA lesions.  
Transcatheter ablation lesion sites were accurately identified with this system in an 
animal model.   
The purpose of TCA is to block or isolate electrical conduction of a cardiac 
arrhythmia.  To be a relevant method for clinical evaluation of RFA lesions, ARFI image 
lesion assessments must be consistent with electrical substrate modification at the 
imaging site.  The results of the third experimental aim verified the presence of 
conduction disturbances at ARFI imaging determined RFA sites, thereby confirming the 
lesion assessment was consistent with the clinical gold-standard for lesion evaluation.   
In the last aim, the feasibility of identifying RFA lesions based on the tissue 
stiffness at clinically relevant sites in human myocardium was investigated.  Results 
from a pilot study of ARFI imaging in human patients undergoing TCA for AF 
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confirmed ARFI imaging measured a decrease in the relative tissue stiffness at RFA sites.  
These results support the undertaking of a larger clinical trial. 
Until this point, MRI and computed tomography (CT) have dominated the effort 
to develop an imaging method for RFA lesion characterization during clinical cardiac 
ablation procedures.  This work is the first to demonstrate that the difference in the 
tissue elasticity between normal and ablated myocardium can be used as an indicator of 
lesion location and size.  While ARFI imaging was the only modality used to 
characterize the stiffness change in this thesis, other imaging modalities could emerge 
that take advantage of the elasticity contrast shown in this work.  The promising results 
of this research also establish ARFI imaging as a potential tool for intraprocedure lesion 
characterization during clinical TCA, and this work should encourage the commercial 
development of ARFI imaging tools and techniques for the assessment of cardiac 
ablation lesions. 
7.1.1 Factors for Clinical Translation 
ARFI imaging shows great potential for RFA lesion evaluation in clinical TCA 
procedures.  Development and optimization of the technology and methods are needed, 
but the results presented in this thesis lay the groundwork for clinical feasibility of this 
technology.  
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As previously mentioned, the clinical equipment needed to implement ARFI 
imaging is currently used in TCA procedures.  Therefore, the integration of a multi-
modality ARFI imaging-EAM system into existing EP labs may not require a significant 
investment in equipment.  The expenses and resources needed to obtain and operate the 
systems would also be substantially less burdensome for rural and developing world 
centers than other complex imaging solutions for lesion characterization such as MRI. 
Introduction of the ICE imaging catheter into the LA is not a common practice 
for the majority of electrophysiologists, and the catheter manipulation techniques 
needed to obtain useful images would require practice and would improve with 
experience.  Regardless, additional training to implement a clinical ARFI imaging 
system would be minimal for current clinical operators because it uses existing clinical 
imaging tools. 
7.1.2 Significance for Procedure Safety 
ARFI imaging could be used to investigate optimal site-specific RF-energy 
dosages for different regions of the heart.    Visual feedback of lesion size and placement 
would determine the amount of RF-energy necessary to completely ablate the target site, 
while minimizing damage to collateral tissue. 
Due to the unpredictability of determining pathological lesion size based on the 
RF-energy delivery parameters, particularly when using irrigated ablation catheters 
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where the ablation is not temperature controlled, clinical operators may apply excessive 
RF-energy at a target site to improve the likelihood of complete ablation.  In some cases, 
such over-titration of RF-energy can cause life-threatening complications during the 
ablation procedure, in particular: 1) perforation of the cardiac wall due to a “steam pop” 
in overheated myocardium (cardiac tamponade) or 2) severe  damage to the esophagus 
due to excessive RF-energy delivery in the adjoining myocardium (transesophageal 
fistula).4, 84  The ability to directly visualize RFA lesions in the myocardium during the 
ablation procedure would provide feedback to help minimize RF-energy delivery.  
Optimization of the RF-energy delivery could reduce procedural complications caused 
by excessive RFA and improve overall procedure safety.   
7.2 Continuing Efforts and Future Work 
7.2.1 Development of a Clinically Approved ARFI Imaging-EAM System 
An approved integrated platform for the ACUSON SC2000™ ultrasound scanner 
(Siemens Healthcare; Issaquah, WA) and CARTO 3™ and SoundStar™ (Biosense 
Webster; Diamond Bar, CA) was recently announced.  This platform can be used for a 
clinically approved version of the integrated system described in chapter 4.   
An integrated SC2000-CARTO 3 clinical system is currently being developed for 
ARFI imaging, and images have been gathered in four patients undergoing catheter 
ablation with an introductory version of this system (Duke IRB approved).  Work on a 
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clinical imaging tool for the SC2000 scanner is also currently in progress.  A preliminary 
image from a patient imaged with the system in shown in figure 32.   
This system will provide a platform for conducting larger scale clinical studies 
for intracardiac ARFI imaging, including: 1) assessing the temporal-spatial stability of 
acute RFA lesions in human myocardium, 2) the reliability of differentiating complete 
electrical block from transient electrical block based on the tissue stiffness, 3) and 
characterization of chronic RFA lesions that are primarily composed of fibrotic scar.   
 
 
Figure 32: ARFI imaging with an integrated SC2000-CARTO3 imaging system.  
Panel A depicts an EAM geometry merged with a registered MRI image (CARTO 
3™/CARTOMerge™).  The ICE catheter and the 2-D ICE imaging plan are projected 
in EAM, and points of RFA are denoted by red spheres.  Panel B and C are the ICE 
and ARFI images corresponding to the projected imaging plane in A.  The arrow in all 
panels denotes a point of interest where the measured ARFI-induced displacements 
suggested an unablated gap between RFA lesions. 
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7.2.2 Development of 3-D ARFI Imaging 
Precisely aligning the straight 2-D ARFI imaging plane to cross-sect lines of 
irregular RFA lesions is challenging.  Misalignment with the lesion line could generate 
ambiguous images of potential lesion line gaps.  For example, figure 32 shows an 
unablated area in the center of the imaging location; it is not clear when examining the 
EAM markers if this gap corresponds to a discontinuity in the lesion line or is rather the 
result of imaging slightly inside the curved lesion line.  While additional 2-D ARFI 
images in this area or validation of electrical connection could clarify the significance of 
the gap, 3-D ARFI imaging would greatly improve the ease and the reliability of 
characterizing such discontinuities.  ARFI imaging in 3-D could also reduce the 
dependence on EAM for guidance when imaging RFA sites.  Siemens Healthcare 
recently released the AcuNav V™, a 3-D ICE imaging catheter for the SC2000 ultrasound 
scanner.  ARFI imaging development for this novel intracardiac transducer is underway. 
7.2.3 Optimization of Intracardiac ARFI Imaging Sequences and 
Displacement Motion Filtering 
Before the launch of widespread clinical trials, steps must be taken to optimize 
the ARFI imaging sequences and processing methods for image formation and display 
in a clinical setting.  A thorough investigation of the optimal configuration of pre and 
post-excitation track-lines, priming pulse application, line sampling density, and 
maximum steering angle could improve the ARFI imaging quality.   
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The optimal motion filtering technique for intracardiac ARFI imaging also 
requires further investigation.  It has been shown that extrapolation motion filters offer 
the best estimate of cardiac motion immediately after the ARFI-excitation (0.1 ms), 
whereas interpolation motion filters better estimate the physiological motion during the 
post-excitation tissue recovery (0.7 ms).130  It was also shown that a quadratic fit may not 
be an ideal estimate for the physiological motion profile.130  More sophisticated 
physiological motion estimation functions and catheter kick-back filtering methods 
could reduce the bias and jitter in the displacement estimations and improve image 
quality.  Current motion filters are applied to each individual pixel with no regard for 
the estimated motion of neighboring pixels.  Motion filtering techniques that employ a 
spatially-interpolative algorithm are under investigation.  Application of a “no push” or 
zero power ARFI-excitation sequence to monitor the pure physiological motion at the 
imaging location may also prove a useful tactic for filtering the ARFI-induced 
displacement estimations. 
7.2.4 Correlation of ARFI Images to Tissue Histology, Ablation 
Temperature, and Electrical Viability 
Further investigation of the histological significance of the stiffness and stiffness 
gradients seen in ARFI images is recommended.  A direct comparison of the ARFI 
images to the ex vivo tissue cellular level histology has not been completed due to the 
difficulty of accurately aligning the imaging plane to the histology slice.  Methods to 
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acquire spatially registered ex vivo histology and ARFI images are currently in 
discussion. 
Plans are underway to modify the experimental setup presented in chapter 3 to 
characterize the relationship between RF-induced tissue damage as measured by the 
relative myocardial stiffness in ARFI images and the ablation temperature and electrical 
conductivity at the ablation site.  An investigation of the ability of ARFI imaging to 
accurately differentiate complete thermocoagulation necrosis from reversibly stunned 
myocardium is also in progress.  Such experiments will provide valuable insight for 
ARFI imaging technologies, as well as increasing the general understanding of the bio-
physical mechanisms of RFA. 
7.2.5 ARFI imaging During Atrial Fibrillation 
It is possible to acquire ARFI images during AF, although the images cannot be 
ECG-gated to diastole and may be overwhelmed by motion artifacts.  Possible methods 
for acquiring interpretable images of RFA lesions and tissue elasticity during AF are 
under investigation; different types of ARFI-based imaging methods, for example fast 
rate stiffness monitoring with ARFI m-mode and composite ARFI images built from 
sequential un-gated acquisitions, may prove to be useful tools for identifying RFA 
lesions during AF. 
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7.2.6 Evaluation of Other Ablation Modalities with ARFI imaging 
While radiofrequency ablation is currently the most common ablation modality 
used in clinical practice, other ablation modalities such as cryoablation and laser 
ablation are gaining popularity in PVI occlusion-ablation devices.82, 163, 164  It is likely that 
any hyperthermic ablation modality (laser, microwave) would exhibit a similar 
thermocoagulation response to RFA, and could potentially be evaluated with ARFI 
imaging.   
The mechanism for tissue necrosis is significantly different for hypothermic 
cryoablation.165  A preliminary feasibility study found ARFI imaging can visualize 
cryoablation lesions in vivo; it is conjectured that cell rapture and severe interstitial 
edema increases the stiffness at the ablation site, but further work is necessary to 
evaluate the feasibility of characterizing cryoablation lesions with ARFI imaging.166 
The experimental method presented in chapter 3 would be a powerful validation 
tool for testing new ablation catheter designs due to its unique ability to capture 
snapshots of the lesion size and morphology within living myocardium during lesion 
formation.  In recent years, contact-force catheters have been developed to increase the 
confidence of the myocardium-electrode contact during lesion delivery.15, 16, 167, 168  ARFI 
imaging could be a useful tool for confirming and optimizing the force necessary for 
complete transmural ablation. 
 123 
 
Appendix A:  Introduction to CARTO 
 
 
Electroanatomical mapping and navigation systems are widely used in clinical 
ablation procedures.4  The CARTO XP™ EP navigation system (Biosense Webster®, Inc., 
Diamond Bar, CA) was developed to serve four main functions: 1) accurately locate the 
3D location of catheter tips without fluoroscopy, 2) construct a 3D geometric 
representation of relevant cardiac chambers and anatomy using points locations 
cataloged from the catheter positions, 3) tag important locations in the chamber 
geometry, such as RFA delivery locations, and 4) capture and map local electrical 
information onto the 3D geometries for large scale understanding of the complex 
arrhythmia.41 
A.1 Magnetic Tracking 
A coil placed in a magnetic field will generate an electrical current that is 
dependent on the field strength and the orientation of the coil within the field.  The 
CARTO navigation system triangulates the position and orientation of the mapping 
catheter (NaviStar™) and ultrasound (SoundStar™) catheter tips in using location 
sensor coils in the catheter tip.  The coils measure the magnetic field generated by a 
magnetic location pad mounted to the procedure table directly under the patient’s 
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thoracic cavity; the pad generates three low strength (5x10-6 to 5x10-5 Tesla) magnetic 
fields that decay as a function of distance from the pad.169  The heart is contained in the 
mapping area, and the location sensor measures the strength of the magnetic field.  The 
strength of the magnetic field determines the distance of the sensor from each of the 
three magnetic field sources.  The distances are considered radii of theoretical spheres 
around the field origins, and the calculated intersection of the three spheres is the spatial 
location of the catheter tip sensor.  The CARTO XP system has been shown to locate the 
catheter tip to within 1 mm of the actual 3-D position.97 
A.2 CARTO Maps 
Figure 33 shows an example of a CARTO geometry map.  The 3-D positions of 
the catheter tips are displayed in the CARTO software relative to a stationary reference 
patch attached to the back of the patient.  A 3-D volume of the cardiac chamber is 
constructed by maneuvering the NaviStar™ to multiple locations along the endocardial 
walls and plotting the relative tip positions.  The heart chamber geometry is interpolated 
from a point catalog of the acquired mapping catheter positions. 
During RFA, the NaviStar™ tip location is marked on the 3D geometry to 
indicate an RFA treatment location.  On the map, the RFA spherical point markers are 
purely location tags and do not represent lesion size. 
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The SoundStar™ catheter position is also located in the mapping area.  The 
location and orientation of the ICE catheter and imaging plane can be projected in the 
CARTO geometry using the CARTOSound™ module.  One study measured a mean 
distance error of ~1.5 mm between the contour of the endocardium in the ICE plane 
projection and the CARTO geometry in the human LA.170  
 
 
 
 
Figure 33.  CARTO XP™ right atrium (RA) geometry showing RFA markers 
and the orientation of the ICE imaging fan in the geometry (CARTOSound™). 
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Figure 34. CARTO local activation time (LAT) maps of a canine right atrium 
(RA) before (left), after incomplete linear RFA (center), and after complete linear 
ablation (right).  The heart was paced from the coronary sinus (CS).  Color scale 
represents activation time, where red is the earliest activation time and magenta is the 
latest.  White arrow indicates direction of electrical propagation.  Red spheres indicate 
RFA treatment locations.  The white spheres outline the tricuspid annulus. 
 
Conduction maps are constructed before and after RFA to identify the initial 
arrhythmia for ablation and confirm substrate modification.41, 169  The NaviStar™ 
mapping catheter tip collects endocardial EG at each contact position.  Local activation 
times (LAT) are calculated relative to a reference EG, and plotted on the surface of the 3-
D volume using a color scale.  The reference EG is often a separate sensing/pacing 
catheter that is positioned in the CS.  The LAT map provides visualization of the 
electrical propagation through the cardiac chamber and is used to identify 
arrhythmogenic ablation targets and confirm electrical block.  Figure 34 shows example 
LAT maps for a linear ablation. 
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A.3 Magnetic vs. Electric Impedance-Based Mapping Systems 
As previously described, the CARTO XP™ and CARTO 3™ EAM systems locate 
catheter tips and the tip orientation in the heart using magnetic tracking technology.  A 
second type of EAM mapping system in clinical use is the St. Jude Medical NavX™ and 
the next generation Ensite Velocity™ navigation system (St. Jude Medical Inc.; 
Minneapolis, MN).  These systems use external surface patches to generate transthoracic 
electrical fields in three orthogonal directions; the electric field measured by the catheter 
electrode determines the 3-D position of the catheter tip in the mapping area.171, 172  
Unfortunately, while this electrical impedance-based mapping method accurately 
locates catheter tips in the heart, the catheter orientation, specifically the yaw, pitch, and 
roll, cannot be determined with this method.  These orientation parameters are 
necessary to accurately determine the direction of the projected ultrasound imaging 
plane from the ICE catheter.  Therefore, existing electrical impedance-based mapping 
systems cannot be used to guide intraprocedure ARFI imaging as was done with the 
CARTO mapping system in this thesis. 
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Appendix B:  Image Review Considerations 
 
 
 Chapters 4 and 5 presented the accuracy of identifying RFA lesions with ARFI 
imaging based on image reviews from calibrated ARFI image readers.  It is important to 
note that the dynamic range of the displayed maximum ARFI-induced displacement 
was manually chosen for each image.  The chosen dynamic range was selected to 
maximize the contrast and minimize color saturation; the sensitivities and specificities 
reported in these chapters represent the detection accuracy for the chosen display range.  
It must be acknowledged that the selection of a different display dynamic range could 
result in a different image review.  In future work, providing the image reader with a 
control to adjust the display dynamic range during review could provide a more robust 
interpretation of the image, effectively allowing the reader to observe the complete 
receiver operating characteristic (ROC) curve during the analysis.173 
 The reading of the LAT maps to identify conduction disturbances at the imaging 
plane, such as in chapter 5, could also benefit from the inclusion of user controls during 
review.  Providing the reader the ability to rotate the 3-D geometry as well as manually 
adjust the LAT color map gradient would be a more robust review method for future 
projects. 
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